#Coronavirus Disease Research #References (by AMEDEO, June 1 ’24)


  1. June 1 Highlight.
    Am J Respir Crit Care Med. 2024;209:xxxvii-xxxviii.
    PubMed        


    BMJ
  2. REYNOLDS C, Naqvi H
    Better use of data can help to prevent future deaths.
    BMJ. 2024;385:q1181.
    PubMed        
  3. LYNN E
    May top picks: politics, psychological safety, and creativity.
    BMJ. 2024;385:q1166.
    PubMed        
  4. TAYLOR L
    Pandemic treaty: panel calls for “reset” to talks as negotiators miss deadline.
    BMJ. 2024;385:q1193.
    PubMed        
  5. LIMB M
    Labour’s pledge to clear NHS waiting list within five years will be tough to achieve, say leaders.
    BMJ. 2024;385:q1186.
    PubMed        
  6. KMIETOWICZ Z
    Junior doctors in England announce five day walkout ahead of general election.
    BMJ. 2024;385:q1183.
    PubMed        
  7. MAHASE E
    GPs could threaten mass resignation over NHS contract.
    BMJ. 2024;385:q1182.
    PubMed        
  8. WISE J
    Improving infection prevention could avoid 750 000 deaths a year, say experts.
    BMJ. 2024;385:q1163.
    PubMed        
  9. DYER O
    Covid-19: South African disclosures reveal secretive world of nations’ vaccine contracts.
    BMJ. 2024;385:q1172.
    PubMed        


    Clin Infect Dis
  10. WOLFE DN, Arangies E, David GL, Armstrong B, et al
    Development of Next-Generation COVID-19 Vaccines: BARDA Supported Phase 2b Study Designs.
    Clin Infect Dis. 2024 May 28:ciae286. doi: 10.1093.
    PubMed         Abstract available
  11. HILL JA, Martens MJ, Young JH, Bhavsar K, et al
    SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study.
    Clin Infect Dis. 2024 May 27:ciae291. doi: 10.1093.
    PubMed         Abstract available


    Int J Infect Dis
  12. REEKIE J, Stovring H, Nielsen H, Johansen IS, et al
    Development of antibody levels and subsequent decline in individuals with vaccine induced and hybrid immunity to SARS-CoV-2.
    Int J Infect Dis. 2024 May 25:107111. doi: 10.1016/j.ijid.2024.107111.
    PubMed         Abstract available


    Intensive Care Med
  13. OUD L
    Long-term outcomes of critically ill patients with hematological malignancies: what is the impact of the coronavirus disease 2019 pandemic?
    Intensive Care Med. 2024 May 28. doi: 10.1007/s00134-024-07493.
    PubMed        


    J Med Virol
  14. HAN Y, Ma Y, Wang Z, Feng F, et al
    TMPRSS13 promotes the cell entry of swine acute diarrhea syndrome coronavirus.
    J Med Virol. 2024;96:e29712.
    PubMed         Abstract available
  15. BORGOGNA C, Ferrante D, Rosso G, Guglielmetti G, et al
    A prospective humoral immune monitoring study of kidney transplant recipients receiving three doses of SARS-CoV-2 mRNA vaccine.
    J Med Virol. 2024;96:e29710.
    PubMed         Abstract available
  16. PAVIA G, Quirino A, Marascio N, Veneziano C, et al
    Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients.
    J Med Virol. 2024;96:e29708.
    PubMed         Abstract available
  17. KOW CS, Ramachandram DS, Hasan SS, Thiruchelvam K, et al
    Antibiotics in COVID-19: Unveiling disturbing truths through critical scrutiny.
    J Med Virol. 2024;96:e29720.
    PubMed        
  18. CHEN IW, Yu TS, Lin CH, Hung KC, et al
    Effectiveness of nirmatrelvir-ritonavir on severe outcomes of COVID-19: A meta-regression analysis.
    J Med Virol. 2024;96:e29718.
    PubMed        


    J Travel Med
  19. TAY M, Lee B, Ismail MH, Yam J, et al
    Usefulness of aircraft and airport wastewater for monitoring multiple pathogens including SARS-CoV-2 variants.
    J Travel Med. 2024 May 30:taae074. doi: 10.1093.
    PubMed         Abstract available


    J Virol
  20. MARIZZI C, Ajayi PK, McMahon R, Meade PS, et al
    A community science approach to public health and public trust in science.
    J Virol. 2024 May 29:e0082524. doi: 10.1128/jvi.00825.
    PubMed         Abstract available
  21. RAHMAN SM, Buchholz DW, Imbiakha B, Jager MC, et al
    Migraine inhibitor olcegepant reduces weight loss and IL-6 release in SARS-CoV-2-infected older mice with neurological signs.
    J Virol. 2024 May 30:e0006624. doi: 10.1128/jvi.00066.
    PubMed         Abstract available
  22. KARMAKAR S, Das Sarma J
    Human coronavirus OC43 infection remodels connexin 43-mediated gap junction intercellular communication in vitro.
    J Virol. 2024 May 31:e0047824. doi: 10.1128/jvi.00478.
    PubMed         Abstract available


    Lancet
  23. THORNTON J
    Infected blood report release marks a day of shame for the UK.
    Lancet. 2024;403:2276-2277.
    PubMed        
  24. LAXMINARAYAN R, Impalli I, Rangarajan R, Cohn J, et al
    Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance.
    Lancet. 2024 May 20:S0140-6736(24)00878-X. doi: 10.1016/S0140-6736(24)00878.
    PubMed         Abstract available
  25. THE LANCET
    Cyberattacks on health care-a growing threat.
    Lancet. 2024;403:2263.
    PubMed        
  26. KIMBALL AB, Jemec GBE, Sayed CJ, Kirby JS, et al
    Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials.
    Lancet. 2024 May 22:S0140-6736(24)00101-6. doi: 10.1016/S0140-6736(24)00101.
    PubMed         Abstract available
  27. PATERLINI M
    Warnings over Italian health-care devolution.
    Lancet. 2024;403:2279.
    PubMed        


    Lancet Infect Dis
  28. HALL P
    Highlights of ESCMID Global 2024.
    Lancet Infect Dis. 2024;24:e357.
    PubMed        
  29. VENKATESAN P
    Alasdair Macintosh Geddes.
    Lancet Infect Dis. 2024;24:577.
    PubMed        


    Life Sci
  30. PETRY J, Weiser T, Griesbaum L, Schroder K, et al
    1.8-cineole prevents platelet activation and aggregation by activating the cAMP pathway via the adenosine A(2A) receptor.
    Life Sci. 2024 May 27:122746. doi: 10.1016/j.lfs.2024.122746.
    PubMed         Abstract available


    N Engl J Med
  31. WANG JJ, Schonborn L, Warkentin TE, Chataway T, et al
    Antibody Fingerprints Linking Adenoviral Anti-PF4 Disorders.
    N Engl J Med. 2024;390:1827-1829.
    PubMed        
  32. HALABI S, Gostin LO, Egbokhare O, Kavanagh MM, et al
    Global Health Law for a Safer and Fairer World.
    N Engl J Med. 2024;390:1925-1931.
    PubMed        


    Nature
  33. HAN Y, Duan X, Yang L, Nilsson-Payant BE, et al
    Author Correction: Identification of SARS-CoV-2 inhibitors using lung and colonic organoids.
    Nature. 2024 May 29. doi: 10.1038/s41586-024-07593.
    PubMed        


    Science
  34. VAN DER LINDEN S, Kyrychenko Y
    A broader view of misinformation reveals potential for intervention.
    Science. 2024;384:959-960.
    PubMed         Abstract available
  35. ALLEN J, Watts DJ, Rand DG
    Quantifying the impact of misinformation and vaccine-skeptical content on Facebook.
    Science. 2024;384:eadk3451.
    PubMed         Abstract available

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, June 1 ’24)

  1. FRANCO-MAY DA, Gomez-Carballo J, Barrera-Badillo G, Cruz-Ortiz MN, et al
    Low antiviral resistance in Influenza A and B viruses isolated in Mexico from 2010 to 2023.
    Antiviral Res. 2024;227:105918.
    PubMed         Abstract available


    Arch Virol
  2. HE L, Cao J, Xie X, Zhang Y, et al
    Effects and mechanism of Qingke Pingchuan granules against influenza virus infection.
    Arch Virol. 2024;169:130.
    PubMed         Abstract available


    BMC Pediatr
  3. AL-KUWARI MG, Mohammed AM, Abdulmajeed J, Al-Romaihi H, et al
    COVID-19 testing, incidence, and positivity trends among school age children during the academic years 2020-2022 in the State of Qatar: special focus on using CDC indicators for community transmission to evaluate school attendance policies and public
    BMC Pediatr. 2024;24:374.
    PubMed         Abstract available


    BMJ
  4. REYNOLDS C, Naqvi H
    Better use of data can help to prevent future deaths.
    BMJ. 2024;385:q1181.
    PubMed        
  5. LYNN E
    May top picks: politics, psychological safety, and creativity.
    BMJ. 2024;385:q1166.
    PubMed        
  6. TAYLOR L
    Pandemic treaty: panel calls for “reset” to talks as negotiators miss deadline.
    BMJ. 2024;385:q1193.
    PubMed        
  7. LIMB M
    Labour’s pledge to clear NHS waiting list within five years will be tough to achieve, say leaders.
    BMJ. 2024;385:q1186.
    PubMed        
  8. KMIETOWICZ Z
    Junior doctors in England announce five day walkout ahead of general election.
    BMJ. 2024;385:q1183.
    PubMed        
  9. MAHASE E
    GPs could threaten mass resignation over NHS contract.
    BMJ. 2024;385:q1182.
    PubMed        
  10. WISE J
    Improving infection prevention could avoid 750 000 deaths a year, say experts.
    BMJ. 2024;385:q1163.
    PubMed        
  11. DYER O
    Covid-19: South African disclosures reveal secretive world of nations’ vaccine contracts.
    BMJ. 2024;385:q1172.
    PubMed        


    Epidemiol Infect
  12. YI B, Patrasova E, Simunkova L, Rost F, et al
    Investigating the cause of a 2021 winter wave of COVID-19 in a border region in eastern Germany: a mixed-methods study, August to November 2021.
    Epidemiol Infect. 2024;152:e87.
    PubMed         Abstract available


    J Infect
  13. SKAARUP KG, Lassen MCH, Modin D, Johansen ND, et al
    The relative vaccine effectiveness of high-dose vs standard-dose influenza vaccines in preventing hospitalization and mortality: A meta-analysis of evidence from randomized trials.
    J Infect. 2024;89:106187.
    PubMed         Abstract available


    J Virol
  14. CARTER DM, Darby CA, Johnson SK, Carlock MA, et al
    Retraction for Carter et al., “Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses”.
    J Virol. 2024 May 31:e0183223. doi: 10.1128/jvi.01832.
    PubMed        
  15. CARTER DM, Darby CA, Lefoley BC, Crevar CJ, et al
    Correction for Carter et al., “Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses”.
    J Virol. 2024 May 31:e0181323. doi: 10.1128/jvi.01813.
    PubMed        
  16. HUANG Y, Owino SO, Crevar CJ, Carter DM, et al
    Correction for Huang et al., “N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies”.
    J Virol. 2024 May 31:e0112823. doi: 10.1128/jvi.01128.
    PubMed        


    J Virol Methods
  17. MAK WA, Visser W, Koeleman JGM, Ong DSY, et al
    SARS-CoV-2-specific T cell responses: a comparative analysis between QuantiFERON SARS-CoV-2, T-SPOT.COVID, and an in-house Omicron ELISpot.
    J Virol Methods. 2024;327:114949.
    PubMed         Abstract available
  18. HAMILTON S, Zhu M, Cloney-Clark S, Mayes P, et al
    Validation of a severe acute respiratory syndrome coronavirus 2 microneutralization assay for evaluation of vaccine immunogenicity.
    J Virol Methods. 2024;327:114945.
    PubMed         Abstract available
  19. EDWARDS K, Corocher T, Hersusianto Y, Campbell D, et al
    Heparin-mediated PCR interference in SARS-CoV-2 assays and subsequent reversal with heparinase I.
    J Virol Methods. 2024;327:114944.
    PubMed         Abstract available
  20. VASQUEZ V, Orozco J
    Clinical validation of SARS-CoV-2 electrochemical immunosensor based on the spike-ACE2 complex.
    J Virol Methods. 2024;327:114940.
    PubMed         Abstract available
  21. DOSBAA A, Guilbaud R, Yusti AF, Ferre VM, et al
    RSV-GenoScan: An automated pipeline for whole-genome human respiratory syncytial virus (RSV) sequence analysis.
    J Virol Methods. 2024;327:114938.
    PubMed         Abstract available
  22. OUSSET MJ, Pianciola LA, Mazzeo M, Oteiza JM, et al
    Improved SARS-CoV-2 RNA recovery in wastewater matrices using a CTAB-based extraction method.
    J Virol Methods. 2024;327:114918.
    PubMed         Abstract available


    Lancet
  23. PATERLINI M
    Warnings over Italian health-care devolution.
    Lancet. 2024;403:2279.
    PubMed        
  24. THORNTON J
    Infected blood report release marks a day of shame for the UK.
    Lancet. 2024;403:2276-2277.
    PubMed        
  25. BROWN M, Gerrard J, McDougall C, MacPhail J, et al
    Purpura fulminans in young women with influenza and co-infections.
    Lancet. 2024;403:2290-2291.
    PubMed        
  26. THE LANCET
    Cyberattacks on health care-a growing threat.
    Lancet. 2024;403:2263.
    PubMed        


    MMWR Morb Mortal Wkly Rep
  27. HAUSE AM, Moro PL, Baggs J, Zhang B, et al
    Early Safety Findings Among Persons Aged >/=60 Years Who Received a Respiratory Syncytial Virus Vaccine – United States, May 3, 2023-April 14, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:489-494.
    PubMed        
  28. GARG S, Reed C, Davis CT, Uyeki TM, et al
    Outbreak of Highly Pathogenic Avian Influenza A(H5N1) Viruses in U.S. Dairy Cattle and Detection of Two Human Cases – United States, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:501-505.
    PubMed        


    N Engl J Med
  29. HALABI S, Gostin LO, Egbokhare O, Kavanagh MM, et al
    Global Health Law for a Safer and Fairer World.
    N Engl J Med. 2024;390:1925-1931.
    PubMed        


    PLoS Comput Biol
  30. MASSEY A, Boennec C, Restrepo-Ortiz CX, Blanchet C, et al
    Real-time forecasting of COVID-19-related hospital strain in France using a non-Markovian mechanistic model.
    PLoS Comput Biol. 2024;20:e1012124.
    PubMed         Abstract available
  31. FOSTER ZSL, Tupper AS, Press CM, Grunwald NJ, et al
    Krisp: A Python package to aid in the design of CRISPR and amplification-based diagnostic assays from whole genome sequencing data.
    PLoS Comput Biol. 2024;20:e1012139.
    PubMed         Abstract available


    PLoS One
  32. KUCZYK C, Munch K, Nohre M, Stephan M, et al
    Development and testing of a questionnaire on the expectations and experiences with wearing face masks in inpatient and day hospitals.
    PLoS One. 2024;19:e0304140.
    PubMed         Abstract available
  33. HUANG W, Ichikohji T
    How dynamic capabilities enable Chinese SMEs to survive and thrive during COVID-19: Exploring the mediating role of business model innovation.
    PLoS One. 2024;19:e0304471.
    PubMed         Abstract available
  34. HABTEMARIAM S, Hery CM, Zhang X, Yu M, et al
    Association between sociodemographics and change in alcohol or tobacco use behaviors during the COVID-19 pandemic.
    PLoS One. 2024;19:e0304111.
    PubMed         Abstract available
  35. CHEN Y, Li H, Lin J, Su Z, et al
    Association between (DeltaPaO2/FiO2)/PEEP and in-hospital mortality in patients with COVID-19 pneumonia: A secondary analysis.
    PLoS One. 2024;19:e0304518.
    PubMed         Abstract available
  36. ABDUL-MUMIN A, Bimpong KA, Cotache-Condor C, Oppong J, et al
    Impact of the COVID-19 pandemic on perinatal care and outcomes: A retrospective study in a tertiary hospital in Northern Ghana.
    PLoS One. 2024;19:e0301081.
    PubMed         Abstract available
  37. LIU N, Li Y, Jiang M, Liu B, et al
    Trade shocks and trade diversion due to epidemic diseases: Evidence from 110 countries.
    PLoS One. 2024;19:e0301828.
    PubMed         Abstract available
  38. TAO W, Zhou JY
    A study on the “Porter Hypothesis” effect of the regulatory measures of the environmental protection tax law in the post-pandemic era.
    PLoS One. 2024;19:e0304636.
    PubMed         Abstract available
  39. RAK A, Matyushenko V, Prokopenko P, Kostromitina A, et al
    A novel immunofluorescent test system for SARS-CoV-2 detection in infected cells.
    PLoS One. 2024;19:e0304534.
    PubMed         Abstract available
  40. NGOMTCHO SCH, Akenji BM, Tchio-Nighie KH, Fokam J, et al
    SARS-CoV-2 active infection and antibodies amongst health personnel during the outbreak in Cameroon: Strengthening the health system for response to future public health emergencies.
    PLoS One. 2024;19:e0304477.
    PubMed         Abstract available
  41. ZHOU K, Robert M, Seegers V, Blanc-Lapierre A, et al
    Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study.
    PLoS One. 2024;19:e0304556.
    PubMed         Abstract available
  42. WELLSPRING I, Ganesh K, Kreklewetz K
    Walk-in mental health: Bridging barriers in a pandemic.
    PLoS One. 2024;19:e0302543.
    PubMed         Abstract available
  43. ELGEDAWY GA, Samir M, Elabd NS, Elsaid HH, et al
    Metabolic profiling during COVID-19 infection in humans: Identification of potential biomarkers for occurrence, severity and outcomes using machine learning.
    PLoS One. 2024;19:e0302977.
    PubMed         Abstract available
  44. CAO D, Tahir SH, Rizvi SMR, Khan KB, et al
    Exploring the influence of women’s leadership and corporate governance on operational liquidity: The glass cliff effect.
    PLoS One. 2024;19:e0302210.
    PubMed         Abstract available
  45. HEARN R, Selfe J, Cordero MI, Dobbin N, et al
    The effects of person-centred active rehabilitation on symptoms of suspected Chronic Traumatic Encephalopathy: A mixed-methods single case design.
    PLoS One. 2024;19:e0302260.
    PubMed         Abstract available
  46. RAHMAN A, Russell M, Zheng W, Eckrich D, et al
    SARS-CoV-2 infection is associated with an increase in new diagnoses of schizophrenia spectrum and psychotic disorder: A study using the US national COVID cohort collaborative (N3C).
    PLoS One. 2024;19:e0295891.
    PubMed         Abstract available
  47. KIMANI ME, Sarr M
    Association of race/ethnicity and severe housing problems with COVID-19 deaths in the United States: Analysis of the first three waves.
    PLoS One. 2024;19:e0303667.
    PubMed         Abstract available
  48. ARBEL Y, Arbel Y, Kerner A, Kerner M, et al
    Can COVID-19 herd immunity be achieved at a city level?
    PLoS One. 2024;19:e0299574.
    PubMed         Abstract available
  49. YOUSEF CC, Farooq A, Amateau G, Abu Esba LC, et al
    The effect of job and personal demands and resources on healthcare workers’ wellbeing: A cross-sectional study.
    PLoS One. 2024;19:e0303769.
    PubMed         Abstract available
  50. DASARI H, Smyrnova A, Leng J, Ducharme FM, et al
    Feasibility, acceptability, and safety of a novel device for self-collecting capillary blood samples in clinical trials in the context of the pandemic and beyond.
    PLoS One. 2024;19:e0304155.
    PubMed         Abstract available
  51. BREBAN R
    Emergence failure of early epidemics: A mathematical modeling approach.
    PLoS One. 2024;19:e0301415.
    PubMed         Abstract available
  52. ACHEAMPONG E, Husain AA, Dudani H, Nayak AR, et al
    Population infection estimation from wastewater surveillance for SARS-CoV-2 in Nagpur, India during the second pandemic wave.
    PLoS One. 2024;19:e0303529.
    PubMed         Abstract available
  53. PASQUALE DK, Welsh W, Bentley-Edwards KL, Olson A, et al
    Homophily and social mixing in a small community: Implications for infectious disease transmission.
    PLoS One. 2024;19:e0303677.
    PubMed         Abstract available
  54. KEMPTHORNE J, Yogeeswaran K, Sibley CG, Bulbulia JA, et al
    The anatomy of prejudice during pandemic lockdowns: Evidence from a national panel study.
    PLoS One. 2024;19:e0303845.
    PubMed         Abstract available
  55. KLEINAU E, Lamba T, Jaskiewicz W, Gorentz K, et al
    Effectiveness of a chatbot in improving the mental wellbeing of health workers in Malawi during the COVID-19 pandemic: A randomized, controlled trial.
    PLoS One. 2024;19:e0303370.
    PubMed         Abstract available
  56. LE T, Flores M, Omaleki V, Hassani A, et al
    Assessing the impact of institutional mistrust on parental endorsement for COVID-19 vaccination among school communities in San Diego County, California.
    PLoS One. 2024;19:e0295618.
    PubMed         Abstract available
  57. RAKIB MI, Alam MJ, Akter N, Tuhin KH, et al
    Change in hierarchy of the financial networks: A study on firms of an emerging market in Bangladesh.
    PLoS One. 2024;19:e0301725.
    PubMed         Abstract available
  58. VOUTOURI C, Hardin CC, Naranbhai V, Nikmaneshi MR, et al
    Dynamic heterogeneity in COVID-19: Insights from a mathematical model.
    PLoS One. 2024;19:e0301780.
    PubMed         Abstract available
  59. ZHANG EY, Baldwin A, Hundley C, Chang E, et al
    Influence of an extreme event-the COVID-19 pandemic-On establishment of and data collection by a citizen science project.
    PLoS One. 2024;19:e0303429.
    PubMed         Abstract available
  60. ZHAO Y, Liu F, Lin P, Tu Z, et al
    Sleep quality and mental health among Chinese nurses after the COVID-19 pandemic: A moderated model.
    PLoS One. 2024;19:e0295105.
    PubMed         Abstract available
  61. SIMANDJUNTAK DP, Jaenicke EC, Wrenn DH
    Pandemic-induced changes in household-level food diversity and diet quality in the U.S.
    PLoS One. 2024;19:e0300839.
    PubMed         Abstract available
  62. SALMAN M, Zhu Y, Kiran S, Sibt E Ali M, et al
    Corporate social responsibility: A key driver of sustainable development in China’s post-COVID economy.
    PLoS One. 2024;19:e0300209.
    PubMed         Abstract available
  63. BALAMPAMA M, de Walque D, Dow WH, Hemono R, et al
    Influence of COVID-19 on female sex workers in Dar es Salaam, Tanzania: A mixed-methods analysis.
    PLoS One. 2024;19:e0303993.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A
  64. WANG D, Huot M, Mohanty V, Shakhnovich EI, et al
    Biophysical principles predict fitness of SARS-CoV-2 variants.
    Proc Natl Acad Sci U S A. 2024;121:e2314518121.
    PubMed         Abstract available
  65. QU B, Miskey C, Gomer A, Kleinert RDV, et al
    TMPRSS2-mediated SARS-CoV-2 uptake boosts innate immune activation, enhances cytopathology, and drives convergent virus evolution.
    Proc Natl Acad Sci U S A. 2024;121:e2407437121.
    PubMed         Abstract available


    Vaccine
  66. XIE Z, Stallings-Smith S, Patel S, Case S, et al
    COVID-19 booster vaccine uptake and reduced risks for long-COVID: A cross-sectional study of a U.S. adult population.
    Vaccine. 2024 Apr 25:S0264-410X(24)00509-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  67. DORJEE K, Namdon T, Topgyal S, Gyatso U, et al
    Association between Covishield vaccine and menstrual disturbance. Findings from a cross-sectional study among participants of Zero TB cohort in India.
    Vaccine. 2024 Apr 27:S0264-410X(24)00500-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  68. MARINTHE G, Brown G, Cristea M, Kutlaca M, et al
    Predicting vaccination hesitancy: The role of basic needs satisfaction and institutional trust.
    Vaccine. 2024 May 3:S0264-410X(24)00507-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  69. BAGLIVO F, De Angelis L, Magri M, De Nicola I, et al
    The impact of COVID-19 vaccination campaign on pediatric vaccine uptake based on parents’ attitudes towards mandatory and recommended vaccination in Southern Italy.
    Vaccine. 2024 May 3:S0264-410X(24)00513-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  70. CHRISTOU-ERGOS M, Bleicher K, Leask J
    Factors associated with vaccination intention and uptake over time in a sample of older Australians.
    Vaccine. 2024 May 3:S0264-410X(24)00508-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  71. ADINUGROHO I, Stafford T, Bentall RP
    The correlation between conspiracy mentality and vaccine intentions is moderated by social events: Evidence from longitudinal data during COVID-19 pandemic in the UK.
    Vaccine. 2024 May 3:S0264-410X(24)00510-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  72. CARDENAS V, Le Gars M, Truyers C, Ruiz-Guinazu J, et al
    Safety and immunogenicity of Ad26.COV2.S in adults: A randomised, double-blind, placebo-controlled Phase 2a dose-finding study.
    Vaccine. 2024;42:3536-3546.
    PubMed         Abstract available
  73. MARANTOS T, Kyriazopoulou E, Angelakis E, Kitsos D, et al
    Immunogenicity of a seasonal influenza and a pneumococcal polysaccharide vaccine in multiple sclerosis patients under disease modifying therapies: A single-center prospective study.
    Vaccine. 2024 May 24:S0264-410X(24)00617-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


    Virology
  74. BROGAARD L, Heegaard PMH, Larsen LE, Skovgaard K, et al
    Pulmonary MicroRNA expression after heterologous challenge with swine influenza A virus (H1N2) in immunized and non-immunized pigs.
    Virology. 2024;596:110117.
    PubMed         Abstract available
  75. TIAN Y, Deng Z, Chuai Z, Li C, et al
    A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challenge.
    Virology. 2024;596:110125.
    PubMed         Abstract available


    Virus Res
  76. CHIRUMBOLO S, Franzini M, Tirelli U
    Does PI-ME/CFS recall post-COVID (PASC) syndrome?
    Virus Res. 2024;345:199393.
    PubMed        
  77. CHIEN Y, Huang XY, Yarmishyn AA, Chien CS, et al
    Paracrinal regulation of neutrophil functions by coronaviral infection in iPSC-derived alveolar type II epithelial cells.
    Virus Res. 2024;345:199391.
    PubMed         Abstract available
  78. WANG Y, Yu H, Zhang T, Sun Z, et al
    Associations between genetic mutations in different SARS-CoV-2 strains and negative conversion time of viral RNA among imported cases in Hangzhou: A cross-sectional study.
    Virus Res. 2024;345:199400.
    PubMed         Abstract available
  79. XU C, Wang Z, Yu B, Pan Z, et al
    Simultaneous and ultrafast detection of pan-SARS-coronaviruses and influenza A/B viruses by a novel multiplex real-time RT-PCR assay.
    Virus Res. 2024 May 28:199410. doi: 10.1016/j.virusres.2024.199410.
    PubMed         Abstract available
  80. BAI H, Zhang X, Gong T, Ma J, et al
    A systematic mutation analysis of 13 major SARS-CoV-2 variants.
    Virus Res. 2024;345:199392.
    PubMed         Abstract available
  81. PAYEN SH, Adhikari K, Petereit J, Uppal T, et al
    SARS-CoV-2 superinfection in CD14(+) monocytes with latent human cytomegalovirus (HCMV) promotes inflammatory cascade.
    Virus Res. 2024;345:199375.
    PubMed         Abstract available

#Coronavirus Disease Research #References (by AMEDEO, May 25 ’24)

  1. KO HHT
    Potential consequences of ineffective COVID-19 antiviral management.
    Acad Emerg Med. 2024 May 20. doi: 10.1111/acem.14940.
    PubMed        


    Am J Respir Crit Care Med
  2. SPIESSHOEFER J, Regmi B, Senol M, Jorn B, et al
    Potential Diaphragm Muscle Weakness-related Dyspnea Persists Two Years after COVID-19 and Could Be Improved by Inspiratory Muscle Training: Results of an Observational and an Interventional Trial.
    Am J Respir Crit Care Med. 2024 May 19. doi: 10.1164/rccm.202309-1572.
    PubMed         Abstract available
  3. SALISBURY ML, Markin CR, Fadely TH, Guttentag AR, et al
    Impact of the COVID-19 Pandemic on a Program to Screen for Subclinical Familial Pulmonary Fibrosis.
    Am J Respir Crit Care Med. 2024 May 19. doi: 10.1164/rccm.202401-0034.
    PubMed        


    Ann Intern Med
  4. KEUTE K
    Healing the Sick: A Timeline of Altruism.
    Ann Intern Med. 2024;177:686-687.
    PubMed        
  5. CHOW EJ, Lynch JB, Zerr DM, Riedo FX, et al
    Lessons From the COVID-19 Pandemic: Updating Our Approach to Masking in Health Care Facilities.
    Ann Intern Med. 2024;177:689.
    PubMed        
  6. WEITZ HH, Merli GJ, Carson JL
    Web Exclusive. Annals Consult Guys – Acute Coronary Syndrome and Anemia: When to Transfuse?
    Ann Intern Med. 2024;177:eW240002.
    PubMed        
  7. IORIO A, Laine C
    What You May Have Missed in 2023: Keeping Up With the Constant Flow of New Medical Evidence.
    Ann Intern Med. 2024;177.
    PubMed        


    Antiviral Res
  8. LIANG Y, Xiao W, Peng Y, Zhang S, et al
    Development of Nanoparticle Vaccines Utilizing Designed Fc-Binding Homo-oligomers and RBD-Fc of SARS-CoV-2.
    Antiviral Res. 2024 May 21:105917. doi: 10.1016/j.antiviral.2024.105917.
    PubMed         Abstract available


    BMJ
  9. MAHENDRADHATA Y
    Presidential election brings a challenging future for evidence informed health policies in Indonesia.
    BMJ. 2024;385:q1119.
    PubMed        
  10. MCKEE M
    The Infected Blood Inquiry: we need some honesty and engagement by those in authority.
    BMJ. 2024;385:q1143.
    PubMed        
  11. DYER C
    Infected blood scandal: “Chilling” cover up hid truth for decades, public inquiry finds.
    BMJ. 2024;385:q1139.
    PubMed        
  12. TORJESEN I
    Wastewater management must have greater focus on protecting public health, says report.
    BMJ. 2024;385:q1142.
    PubMed        
  13. RIMMER A
    Physician associates must have a named senior doctor supervising them at all times, says BMA.
    BMJ. 2024;385:q1148.
    PubMed        
  14. YASSAIE R
    Doctors who are activists remind and inspire us also to do the work.
    BMJ. 2024;385:q1138.
    PubMed        
  15. DUNN K, Hamilton Hurwitz H, Toledo JP, Schwaber MJ, et al
    Summary of WHO infection prevention and control guideline for covid-19: striving for evidence based practice in infection prevention and control.
    BMJ. 2024;385:q645.
    PubMed        
  16. NAKWEYA G
    Severe budget cuts in Kenya will plunge country into health crisis, officials warn.
    BMJ. 2024;385:q1154.
    PubMed        
  17. BAHRI C
    The untold health toll of voting.
    BMJ. 2024;385:q1060.
    PubMed        

  18. Seven days in medicine: 15-21 May 2024.
    BMJ. 2024;385:q1130.
    PubMed        
  19. TORJESEN I
    Sixty seconds on . . . prepping.
    BMJ. 2024;385:q1161.
    PubMed        
  20. MURRAY I
    Covid inquiry: What have we learnt about Northern Ireland’s response?
    BMJ. 2024;385:q1160.
    PubMed        


    Emerg Infect Dis
  21. COCOROS NM, Eberhardt K, Nguyen VT, Brown CM, et al
    Electronic Health Record-Based Algorithm for Monitoring Respiratory Virus-Like Illness.
    Emerg Infect Dis. 2024;30:1096-1103.
    PubMed         Abstract available
  22. CHANG T, Cho SI, Yoo DS, Min KD, et al
    Trends in Nationally Notifiable Infectious Diseases in Humans and Animals during COVID-19 Pandemic, South Korea.
    Emerg Infect Dis. 2024;30:1154-1163.
    PubMed         Abstract available
  23. GRIFFIN I, King J, Lyons BC, Singleton AL, et al
    Estimates of SARS-CoV-2 Hospitalization and Fatality Rates in the Prevaccination Period, United States.
    Emerg Infect Dis. 2024;30:1144-1153.
    PubMed         Abstract available
  24. BANKERS L, O’Brien SC, Tapay DM, Ho E, et al
    SARS-CoV-2 Disease Severity and Cycle Threshold Values in Children Infected during Pre-Delta, Delta, and Omicron Periods, Colorado, USA, 2021-2022.
    Emerg Infect Dis. 2024;30:1182-1192.
    PubMed         Abstract available
  25. CUNNINGHAM-OAKES E, Pilgrim J, Darby AC, Appleton C, et al
    Emerging Variants of Canine Enteric Coronavirus Associated with Outbreaks of Gastroenteric Disease.
    Emerg Infect Dis. 2024;30:1240-1244.
    PubMed         Abstract available
  26. CERPAS C, Vasquez G, Moreira H, Juarez JG, et al
    Introduction of New Dengue Virus Lineages of Multiple Serotypes after COVID-19 Pandemic, Nicaragua, 2022.
    Emerg Infect Dis. 2024;30:1203-1213.
    PubMed         Abstract available
  27. CANO-TERRIZA D, Beato-Benitez A, Fernandez-Bastit L, Segales J, et al
    SARS-CoV-2 in Captive Nonhuman Primates, Spain, 2020-2023.
    Emerg Infect Dis. 2024;30:1253-1257.
    PubMed         Abstract available
  28. KINOSHITA R, Miyamoto S, Sakuraba S, Sugihara J, et al
    Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023.
    Emerg Infect Dis. 2024;30:1267-1270.
    PubMed         Abstract available


    Infect Control Hosp Epidemiol
  29. CHEA N, Eure T, Alkis Ramirez R, Zlotorzynska M, et al
    Characteristics of healthcare personnel with SARS-CoV-2 infection: 10 emerging infections program sites in the United States, April 2020-December 2021.
    Infect Control Hosp Epidemiol. 2024 May 21:1-9. doi: 10.1017/ice.2024.
    PubMed         Abstract available


    Int J Infect Dis
  30. CHEMAITELLY H, Akhtar N, Jerdi SA, Kamran S, et al
    Association between COVID-19 vaccination and stroke: a nationwide case-control study in Qatar.
    Int J Infect Dis. 2024 May 20:107095. doi: 10.1016/j.ijid.2024.107095.
    PubMed         Abstract available
  31. RAMONFAUR D, Ayad N, Liu PHZ, Zhou J, et al
    The global clinical studies of long COVID.
    Int J Infect Dis. 2024 May 21:107105. doi: 10.1016/j.ijid.2024.107105.
    PubMed         Abstract available
  32. LI Y, Wu Z, Yan Y, Shi Y, et al
    Corrigendum to “Prevalence of respiratory viruses among hospitalized children with lower respiratory tract infections during the COVID-19 pandemic in Wuhan, China” [International Journal of Infectious Diseases 139 (2024) pages 6-12].
    Int J Infect Dis. 2024;145:107056.
    PubMed        
  33. ZHANG D, Liu S, Peng B, Shi X, et al
    Effects of the timing of maternal SARS-CoV-2 infection and vaccination status on placental transfer of antibodies to neonates: a cross-sectional study.
    Int J Infect Dis. 2024 May 16:107098. doi: 10.1016/j.ijid.2024.107098.
    PubMed         Abstract available


    J Infect
  34. HAN B, Li XM, Li R, Ning W, et al
    Epidemiological Surveillance of Acute Respiratory Infections Based on Targeted Metagenomic Next Generation Sequencing During the Flu Season after COVID-19 Pandemic in Beijing.
    J Infect. 2024 May 22:106188. doi: 10.1016/j.jinf.2024.106188.
    PubMed        
  35. PATERNINA-CAICEDO A, Quevedo DS, Rios DS, Moyano D, et al
    Heterologous and BNT162b2 boosters are more effective than non-mRNA homologous boosters for Omicron.
    J Infect. 2024;88:106165.
    PubMed        


    J Med Virol
  36. HAQUE W, Talha M, Rahman S, Hasan M, et al
    Rotavirus trends and distribution of genotypes before and during COVID-19 pandemic era: Bangladesh, 2017-2021.
    J Med Virol. 2024;96:e29681.
    PubMed         Abstract available
  37. AMOROSO MG, Pucciarelli A, Serra F, Ianiro G, et al
    Ten different viral agents infecting and co-infecting children with acute gastroenteritis in Southern Italy: Role of known pathogens and emerging viruses during and after COVID-19 pandemic.
    J Med Virol. 2024;96:e29679.
    PubMed         Abstract available
  38. GONG S, Ma C, Ma R, Zhu T, et al
    Elevated pretreatment serum apolipoprotein E level associated with poor prognosis of patients with COVID-19 during the omicron BA.5 and BF.7 wave.
    J Med Virol. 2024;96:e29673.
    PubMed         Abstract available
  39. AKANCHISE T, Angelov B, Angelova A
    Nanomedicine-mediated recovery of antioxidant glutathione peroxidase activity after oxidative-stress cellular damage: Insights for neurological long COVID.
    J Med Virol. 2024;96:e29680.
    PubMed         Abstract available
  40. JEONG YD, Lee K, Lee S, Park J, et al
    Global and regional burden of vaccine-associated facial paralysis, 1967-2023: Findings from the WHO international pharmacovigilance database.
    J Med Virol. 2024;96:e29682.
    PubMed         Abstract available


    J Virol
  41. DOMINGO E, Martinez-Gonzalez B, Garcia-Crespo C, Somovilla P, et al
    Correction for Domingo et al., “Puzzles, challenges, and information reservoir of SARS-CoV-2 quasispecies”.
    J Virol. 2024 May 24:e0026324. doi: 10.1128/jvi.00263.
    PubMed        
  42. MA MT, Jiang Q, Chen C-H, Badeti S, et al
    S309-CAR-NK cells bind the Omicron variants in vitro and reduce SARS-CoV-2 viral loads in humanized ACE2-NSG mice.
    J Virol. 2024 May 20:e0003824. doi: 10.1128/jvi.00038.
    PubMed         Abstract available


    JAMA
  43. HARRIS E
    Monoclonal Antibody Authorized to Protect At-Risk People From COVID-19.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8628.
    PubMed        
  44. DEVEREUX G, Cotton S, Nath M, McMeekin N, et al
    Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial.
    JAMA. 2024 May 19. doi: 10.1001/jama.2024.8771.
    PubMed         Abstract available
  45. BOCK A
    Researchers See Hope in Symptom-Guided Exercise for Long COVID With Postexertional Malaise.
    JAMA. 2024;331:1609-1611.
    PubMed        


    Lancet
  46. SAMARASEKERA U
    50 years of the Expanded Programme on Immunization.
    Lancet. 2024;403:1971-1972.
    PubMed        

  47. Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024;403:2204-2256.
    PubMed         Abstract available
  48. MARCATO AJ, Meagher N, Spirkoska V, Arnott A, et al
    One Health pandemic preparedness: the role of companion animals in disease transmission.
    Lancet. 2024;403:1984-1985.
    PubMed        
  49. ADAMU AA, Ndwandwe D, Jalo RI, Muhammad ID, et al
    Cofinancing immunisation through national health insurance.
    Lancet. 2024;403:1983-1984.
    PubMed        
  50. HORTON R
    Offline: Indifference-the biggest threat to global health.
    Lancet. 2024;403:1970.
    PubMed        
  51. KANTER R, Fort MP
    Rethinking health policy: life expectancy and mortality in an era of polycrisis.
    Lancet. 2024;403:1956-1958.
    PubMed        


    Lancet Infect Dis
  52. INGHAMMAR M, Kahn F
    Immune evasiveness of SARS-CoV-2 variants and vaccine selection.
    Lancet Infect Dis. 2024 May 15:S1473-3099(24)00286.
    PubMed        
  53. MOUSTSEN-HELMS IR, Bager P, Larsen TG, Moller FT, et al
    Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study.
    Lancet Infect Dis. 2024 May 15:S1473-3099(24)00220.
    PubMed         Abstract available
  54. KAKU Y, Uriu K, Kosugi Y, Okumura K, et al
    Virological characteristics of the SARS-CoV-2 KP.2 variant.
    Lancet Infect Dis. 2024 May 20:S1473-3099(24)00298.
    PubMed        


    MMWR Morb Mortal Wkly Rep
  55. TUTTLE A, Hughes CM, Dvorak M, Aeschleman L, et al
    Notes from the Field: Clade II Mpox Surveillance Update – United States, October 2023-April 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:474-476.
    PubMed        
  56. CLEMENS T, Moreland B, Mack KA, Thomas K, et al
    Vital Signs: Drowning Death Rates, Self-Reported Swimming Skill, Swimming Lesson Participation, and Recreational Water Exposure – United States, 2019-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:467-473.
    PubMed         Abstract available
  57. GUAGLIARDO SAJ, Kracalik I, Carter RJ, Braden C, et al
    Monkeypox Virus Infections After 2 Preexposure Doses of JYNNEOS Vaccine – United States, May 2022-May 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:460-466.
    PubMed         Abstract available


    Nature
  58. EWBANK J
    Trials that infected people with common colds can inform today’s COVID-19 challenge trials.
    Nature. 2024;629:757.
    PubMed        

  59. A global pandemic treaty is in sight: don’t scupper it.
    Nature. 2024;629:727.
    PubMed        
  60. WOOLSTON C
    How researchers in remote regions handle the isolation.
    Nature. 2024;629:1193-1195.
    PubMed        


    Pol J Radiol
  61. LYZNIAK P, Swieton D, Szurowska E
    Lung ultrasound in a nutshell. Lines, signs, some applications, and misconceptions from a radiologist’s point of view. Part 2.
    Pol J Radiol. 2024;89:e211-e224.
    PubMed         Abstract available


    Science
  62. BENGIO Y, Hinton G, Yao A, Song D, et al
    Managing extreme AI risks amid rapid progress.
    Science. 2024;384:842-845.
    PubMed         Abstract available
  63. KAISER J
    U.S. blocks funding for pandemic research group.
    Science. 2024;384:832-833.
    PubMed         Abstract available

#Influenza and Other Respiratory #Viruses Research #References (AMEDEO, May 25 ’24)

  1. KEUTE K
    Healing the Sick: A Timeline of Altruism.
    Ann Intern Med. 2024;177:686-687.
    PubMed        
  2. CHOW EJ, Lynch JB, Zerr DM, Riedo FX, et al
    Lessons From the COVID-19 Pandemic: Updating Our Approach to Masking in Health Care Facilities.
    Ann Intern Med. 2024;177:689.
    PubMed        
  3. IORIO A, Laine C
    What You May Have Missed in 2023: Keeping Up With the Constant Flow of New Medical Evidence.
    Ann Intern Med. 2024;177.
    PubMed        
  4. ALHAMMADI A, Alshawaf R, Chavda S, Ramondino S, et al
    Infectious Diseases: What You May Have Missed in 2023.
    Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0679.
    PubMed         Abstract available
  5. COSCHI CH, Dodbiba L, Guerry D
    Oncology: What You May Have Missed in 2023.
    Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0520.
    PubMed         Abstract available
  6. ALHABOBI AAM, Almutairi AMS, Bohemid DASY, Sehgal AR, et al
    Nephrology: What You May Have Missed in 2023.
    Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0605.
    PubMed         Abstract available
  7. RADCLIFFE C, Kotton CN
    En Garde or On Board? Travel Medicine for Immunocompromised Patients in the COVID-19 Era.
    Ann Intern Med. 2024 Apr 9. doi: 10.7326/M24-0256.
    PubMed        
  8. WELLS CR, Pandey A, Moghadas SM, Fitzpatrick MC, et al
    Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination Campaigns in the United States.
    Ann Intern Med. 2024 Mar 26. doi: 10.7326/M23-2451.
    PubMed         Abstract available


    Antiviral Res
  9. LIU X, Wang Y, Sun L, Xiao G, et al
    Screening and optimization of shark nanobodies against SARS-CoV-2 Spike RBD.
    Antiviral Res. 2024 Apr 29:105898. doi: 10.1016/j.antiviral.2024.105898.
    PubMed         Abstract available
  10. ARDUINO I, Francese R, Civra A, Feyles E, et al
    Polyoxometalate exerts broad-spectrum activity against human respiratory viruses hampering viral entry.
    Antiviral Res. 2024;226:105897.
    PubMed         Abstract available
  11. GLITSCHER M, Benz NI, Sabino C, Murra RO, et al
    Inhibition of Pim kinases triggers a broad antiviral activity by affecting innate immunity and via the PI3K-Akt-mTOR axis the endolysosomal system.
    Antiviral Res. 2024;226:105891.
    PubMed         Abstract available
  12. GUO M, Peng J, Guo P, Wang Q, et al
    Inhalation of 2, 4-di-tert-butylphenol-Loaded micelles suppresses respiratory syncytial virus infection in mice.
    Antiviral Res. 2024;226:105880.
    PubMed         Abstract available
  13. TOLKSDORF B, Heinze J, Niemeyer D, Rohrs V, et al
    Development of a highly stable, active small interfering RNA with broad activity against SARS-CoV viruses.
    Antiviral Res. 2024 Apr 8:105879. doi: 10.1016/j.antiviral.2024.105879.
    PubMed         Abstract available


    Biochem Biophys Res Commun
  14. GAUR NK, Urankar S, Sengupta D, Chepuri VR, et al
    A cell based assay using virus-like particles to screen AM type mimics for SARS-CoV-2 neutralisation.
    Biochem Biophys Res Commun. 2024;718:150082.
    PubMed         Abstract available


    Biochemistry
  15. PETERSON JM, Becker ST, O’Leary CA, Juneja P, et al
    Structure of the SARS-CoV-2 Frameshift Stimulatory Element with an Upstream Multibranch Loop.
    Biochemistry. 2024;63:1287-1296.
    PubMed         Abstract available


    BMC Pediatr
  16. SARBAZI E, Masoudi N, Mehri A, Esfanjani RM, et al
    Trust in primary health care and COVID-19 vaccine uptake among Iranian pediatric: a web-based cross-sectional survey.
    BMC Pediatr. 2024;24:356.
    PubMed         Abstract available
  17. LI S, Xiao W, Li H, Hu D, et al
    Identification of neurological complications in childhood influenza: a random forest model.
    BMC Pediatr. 2024;24:347.
    PubMed         Abstract available


    BMJ
  18. MURRAY I
    Covid inquiry: What have we learnt about Northern Ireland’s response?
    BMJ. 2024;385:q1160.
    PubMed        
  19. TORJESEN I
    Sixty seconds on . . . prepping.
    BMJ. 2024;385:q1161.
    PubMed        

  20. Seven days in medicine: 15-21 May 2024.
    BMJ. 2024;385:q1130.
    PubMed        
  21. BAHRI C
    The untold health toll of voting.
    BMJ. 2024;385:q1060.
    PubMed        
  22. LOOI MK
    Bird flu: US confirms second human case in two months.
    BMJ. 2024;385:q1156.
    PubMed        
  23. NAKWEYA G
    Severe budget cuts in Kenya will plunge country into health crisis, officials warn.
    BMJ. 2024;385:q1154.
    PubMed        
  24. DUNN K, Hamilton Hurwitz H, Toledo JP, Schwaber MJ, et al
    Summary of WHO infection prevention and control guideline for covid-19: striving for evidence based practice in infection prevention and control.
    BMJ. 2024;385:q645.
    PubMed        
  25. YASSAIE R
    Doctors who are activists remind and inspire us also to do the work.
    BMJ. 2024;385:q1138.
    PubMed        
  26. RIMMER A
    Physician associates must have a named senior doctor supervising them at all times, says BMA.
    BMJ. 2024;385:q1148.
    PubMed        
  27. TORJESEN I
    Wastewater management must have greater focus on protecting public health, says report.
    BMJ. 2024;385:q1142.
    PubMed        
  28. DYER C
    Infected blood scandal: “Chilling” cover up hid truth for decades, public inquiry finds.
    BMJ. 2024;385:q1139.
    PubMed        
  29. MCKEE M
    The Infected Blood Inquiry: we need some honesty and engagement by those in authority.
    BMJ. 2024;385:q1143.
    PubMed        
  30. MAHENDRADHATA Y
    Presidential election brings a challenging future for evidence informed health policies in Indonesia.
    BMJ. 2024;385:q1119.
    PubMed        


    Epidemiol Infect
  31. LASANDER M, Elo K, Joronen K, Dub T, et al
    Barriers to vaccine acceptance in the adult population of mainland Finland, 2021 – ERRATUM.
    Epidemiol Infect. 2024;152:e79.
    PubMed        
  32. BEALE S, Yavlinsky A, Fong WLE, Nguyen VG, et al
    Long-term outcomes of SARS-CoV-2 variants and other respiratory infections: evidence from the Virus Watch prospective cohort in England.
    Epidemiol Infect. 2024;152:e77.
    PubMed         Abstract available


    J Immunol
  33. LEIGHTON PA, Ching K, Reynolds K, Vuong CN, et al
    Chickens with a Truncated Light Chain Transgene Express Single-Domain H Chain-Only Antibodies.
    J Immunol. 2024;212:1744-1753.
    PubMed         Abstract available
  34. LEE MJ, de Los Rios Kobara I, Barnard TR, Vales Torres X, et al
    NK Cell-Monocyte Cross-talk Underlies NK Cell Activation in Severe COVID-19.
    J Immunol. 2024;212:1693-1705.
    PubMed         Abstract available


    J Infect
  35. PATERNINA-CAICEDO A, Quevedo DS, Rios DS, Moyano D, et al
    Heterologous and BNT162b2 boosters are more effective than non-mRNA homologous boosters for Omicron.
    J Infect. 2024;88:106165.
    PubMed        
  36. CHUN JY, Jeong SJ, Kim S, Choi S, et al
    Performance of the Galactomannan Test for the Diagnosis of Invasive Pulmonary Aspergillosis using Non-invasive Proximal Airway Samples.
    J Infect. 2024 Apr 17:106159. doi: 10.1016/j.jinf.2024.106159.
    PubMed         Abstract available


    J Virol
  37. KNOLL M, Honce R, Meliopoulos V, Segredo-Otero EA, et al
    Host obesity impacts genetic variation in influenza A viral populations.
    J Virol. 2024 May 24:e0177823. doi: 10.1128/jvi.01778.
    PubMed         Abstract available
  38. SCHWAB LSU, Do THT, Pilapitiya D, Koutsakos M, et al
    Dissemination of influenza B virus to the lower respiratory tract of mice is restricted by the interferon response.
    J Virol. 2024 May 23:e0160423. doi: 10.1128/jvi.01604.
    PubMed         Abstract available


    JAMA
  39. KOJIMA N, Blumberg A, Radcliffe R, Flannery B, et al
    US Public Health Preparedness and Response to Highly Pathogenic Avian Influenza A(H5N1) Viruses.
    JAMA. 2024 May 21:e2410116. doi: 10.1001/jama.2024.10116.
    PubMed        
  40. BOCK A
    Researchers See Hope in Symptom-Guided Exercise for Long COVID With Postexertional Malaise.
    JAMA. 2024;331:1609-1611.
    PubMed        
  41. HARRIS E
    WHO Launches Broad Coronavirus Surveillance Network.
    JAMA. 2024 Apr 26. doi: 10.1001/jama.2024.6724.
    PubMed        
  42. HARRIS E
    CDC: H5N1 Bird Flu Confirmed in Person Exposed to Cattle.
    JAMA. 2024;331:1615.
    PubMed        
  43. ALLEN MR, Desai N, Namazi A, Leas E, et al
    Characteristics of X (Formerly Twitter) Community Notes Addressing COVID-19 Vaccine Misinformation.
    JAMA. 2024 Apr 24:e244800. doi: 10.1001/jama.2024.4800.
    PubMed        


    Lancet
  44. SAMARASEKERA U
    50 years of the Expanded Programme on Immunization.
    Lancet. 2024;403:1971-1972.
    PubMed        
  45. MARCATO AJ, Meagher N, Spirkoska V, Arnott A, et al
    One Health pandemic preparedness: the role of companion animals in disease transmission.
    Lancet. 2024;403:1984-1985.
    PubMed        
  46. ADAMU AA, Ndwandwe D, Jalo RI, Muhammad ID, et al
    Cofinancing immunisation through national health insurance.
    Lancet. 2024;403:1983-1984.
    PubMed        
  47. HORTON R
    Offline: Indifference-the biggest threat to global health.
    Lancet. 2024;403:1970.
    PubMed        
  48. KANTER R, Fort MP
    Rethinking health policy: life expectancy and mortality in an era of polycrisis.
    Lancet. 2024;403:1956-1958.
    PubMed        
  49. KNUPPEL A, Boyd A, Macleod J, Chaturvedi N, et al
    The long COVID evidence gap in England.
    Lancet. 2024 May 6:S0140-6736(24)00744-X. doi: 10.1016/S0140-6736(24)00744.
    PubMed        

  50. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a sys
    Lancet. 2024 Apr 15:S0140-6736(24)00757-8. doi: 10.1016/S0140-6736(24)00757.
    PubMed         Abstract available

  51. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367.
    PubMed         Abstract available

  52. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden
    Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep
  53. CLEMENS T, Moreland B, Mack KA, Thomas K, et al
    Vital Signs: Drowning Death Rates, Self-Reported Swimming Skill, Swimming Lesson Participation, and Recreational Water Exposure – United States, 2019-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:467-473.
    PubMed         Abstract available
  54. TUTTLE A, Hughes CM, Dvorak M, Aeschleman L, et al
    Notes from the Field: Clade II Mpox Surveillance Update – United States, October 2023-April 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:474-476.
    PubMed        


    N Engl J Med
  55. GUAN L, Eisfeld AJ, Pattinson D, Gu C, et al
    Cow’s Milk Containing Avian Influenza A(H5N1) Virus – Heat Inactivation and Infectivity in Mice.
    N Engl J Med. 2024 May 24. doi: 10.1056/NEJMc2405495.
    PubMed        
  56. RUBIN EJ, Baden LR, Daskalakis D, Marston H, et al
    Audio Interview: Preparing for a Possible Avian Influenza Outbreak.
    N Engl J Med. 2024 May 22. doi: 10.1056/NEJMe2406224.
    PubMed        
  57. RUBIN EJ, Baden LR, Marrazzo J, Monto A, et al
    Audio Interview: The Current State of Avian Influenza.
    N Engl J Med. 2024 May 20. doi: 10.1056/NEJMe2406223.
    PubMed        


    PLoS Comput Biol
  58. TRINITY L, Stege U, Jabbari H
    Tying the knot: Unraveling the intricacies of the coronavirus frameshift pseudoknot.
    PLoS Comput Biol. 2024;20:e1011787.
    PubMed         Abstract available


    PLoS Med
  59. EUVRARD J, Timmerman V, Keene CM, Phelanyane F, et al
    The cyclical cascade of HIV care: Temporal care engagement trends within a population-wide cohort.
    PLoS Med. 2024;21:e1004407.
    PubMed         Abstract available


    PLoS One
  60. QING W, Xuebo Z
    Rational resistance amidst gentle breeze and mild rain: Examining online collective behavior among the Chinese public using the elaborated social identity model.
    PLoS One. 2024;19:e0303603.
    PubMed         Abstract available
  61. ROBOTTO A, Olivero C, Pozzi E, Strumia C, et al
    Efficient wastewater sample filtration improves the detection of SARS-CoV-2 variants: An extensive analysis based on sequencing parameters.
    PLoS One. 2024;19:e0304158.
    PubMed         Abstract available
  62. NGOC BH, Hoang CC, Tram NHM
    A time-varying analysis between economic uncertainty and tourism development in Singapore.
    PLoS One. 2024;19:e0302980.
    PubMed         Abstract available
  63. LIU Y, Goh CH, Shen D, Qiu H, et al
    The incidence of thrombosis with co-occurring thrombocytopenia prior to the SARS-CoV2 pandemic: A population-based study.
    PLoS One. 2024;19:e0301359.
    PubMed         Abstract available
  64. CHEN J, Sun J, Wei S, You X, et al
    Does strategic coupling of TNCs affect their exit from host regions: Empirical analysis of the exit of Taiwanese enterprises from mainland China.
    PLoS One. 2024;19:e0304254.
    PubMed         Abstract available
  65. LLANOS N, Iglesias L, Galvez Espinoza P, Cuevas C, et al
    Food and family care during the COVID-19 pandemic: A study of women’s domestic workload during the first wave in Chile.
    PLoS One. 2024;19:e0301038.
    PubMed         Abstract available
  66. ANDRADE GC, Caldeira TCM, Mais LA, Bortoletto Martins AP, et al
    Food price trends during the COVID-19 pandemic in Brazil.
    PLoS One. 2024;19:e0303777.
    PubMed         Abstract available
  67. APRININGSIH, Hanifah L, Nasrulloh N
    Exclusive breastfeeding practice during COVID-19 pandemic in West Java Indonesia: A cross-sectional study.
    PLoS One. 2024;19:e0303386.
    PubMed         Abstract available
  68. LAU WY, Ke GN, Yip TM, Wong RMM, et al
    Socioeconomic impact and sufficiency of government financial support during COVID-19 pandemic: A retrospective study.
    PLoS One. 2024;19:e0302979.
    PubMed         Abstract available
  69. KASZTELEWICZ B, Skrok K, Burzynska J, Migdal M, et al
    Incidence of SARS-CoV-2 infection among healthcare workers before and after COVID-19 vaccination in a tertiary paediatric hospital in Warsaw: A retrospective cohort study.
    PLoS One. 2024;19:e0301612.
    PubMed         Abstract available
  70. ITAM MF, Minhat HS, Abd Rahman A, Ibrahim MZ, et al
    The COVID-19 pandemic related stress and the associated factors among the healthcare workers in Kota Setar District Health Office, Malaysia.
    PLoS One. 2024;19:e0301469.
    PubMed         Abstract available
  71. ISHIGAKI Y, Yokogawa S
    Monitoring the ventilation of living spaces to assess the risk of airborne transmission of infection using a novel Pocket CO2 Logger to track carbon dioxide concentrations in Tokyo.
    PLoS One. 2024;19:e0303790.
    PubMed         Abstract available
  72. ALLO G, Sitarik AR, Redding A, Coleman CM, et al
    Maternal COVID-19 exposure and placental characteristics.
    PLoS One. 2024;19:e0302682.
    PubMed         Abstract available
  73. ROLDAN CJ, Prasetyo YT, Ong AKS, Ayuwati ID, et al
    Copywriters’ preference evaluation on online copywriting course attributes during the COVID-19 pandemic.
    PLoS One. 2024;19:e0292467.
    PubMed         Abstract available
  74. LEWANDOWSKI ME, Delawalla CN, Butcher TJ, Oberlin BG, et al
    Changes in substance use, recovery, and quality of life during the initial phase of the COVID-19 pandemic.
    PLoS One. 2024;19:e0300848.
    PubMed         Abstract available
  75. LOOKER KJ, McClenaghan E, Judd A, Pierotti L, et al
    Acute and long-term outcomes of SARS-CoV-2 infection in school-aged children in England: Study protocol for the joint analysis of the COVID-19 schools infection survey (SIS) and the COVID-19 mapping and mitigation in schools (CoMMinS) study.
    PLoS One. 2024;19:e0303892.
    PubMed         Abstract available
  76. YING X, Peng H, Xie J
    Big data analysis for Covid-19 in hospital information systems.
    PLoS One. 2024;19:e0294481.
    PubMed         Abstract available
  77. CHANG SC, Grunkemeier GL, Goldman JD, Wang M, et al
    A simplified pneumonia severity index (PSI) for clinical outcome prediction in COVID-19.
    PLoS One. 2024;19:e0303899.
    PubMed         Abstract available
  78. TASSANEEYASIN T, Sungkanuparph S, Srichatrapimuk S, Charoensri A, et al
    Prevalence and risk factors of cytomegalovirus reactivation in critically Ill patients with COVID-19 pneumonia.
    PLoS One. 2024;19:e0303995.
    PubMed         Abstract available
  79. BOOIJ-TROMP FM, van Groningen NJ, Vervuurt S, Haagsma JA, et al
    Association between stringency of lockdown measures and emergency department visits during the COVID-19 pandemic: A Dutch multicentre study.
    PLoS One. 2024;19:e0303859.
    PubMed         Abstract available
  80. QU Y, Lee CY
    Estimation of standardized real-time fatality rate for ongoing epidemics.
    PLoS One. 2024;19:e0303861.
    PubMed         Abstract available
  81. FUKUI N, Li SS, DeGuzman J, Myers JF, et al
    Mixed methods approach to examining the implementation experience of a phone-based survey for a SARS-CoV-2 test-negative case-control study in California.
    PLoS One. 2024;19:e0301070.
    PubMed         Abstract available
  82. OH AR, Kang ES, Park J, Lee SM, et al
    Does coronavirus disease 2019 history alone increase the risk of postoperative pulmonary complications after surgery? Prospective observational study using serology assessment.
    PLoS One. 2024;19:e0300782.
    PubMed         Abstract available
  83. PAUL O, Akolia IK, Qin Tao J, Jain N, et al
    Reactive oxygen species in endothelial signaling in COVID-19: Protective role of the novel peptide PIP-2.
    PLoS One. 2024;19:e0289854.
    PubMed         Abstract available
  84. SHARMA M, Sra H, Painter C, Pan-Ngum W, et al
    Cost-effectiveness analysis of surgical masks, N95 masks compared to wearing no mask for the prevention of COVID-19 among health care workers: Evidence from the public health care setting in India.
    PLoS One. 2024;19:e0299309.
    PubMed         Abstract available
  85. SUAIFAN GARY, Abu-Odeh AM, Shehadeh MB, Jbara FA, et al
    A cross-sectional study on adult lifestyle habits during the COVID-19 pandemic.
    PLoS One. 2024;19:e0299668.
    PubMed         Abstract available
  86. LEVANO DC, Lopez SE, Gherasim A, Dominguez JO, et al
    The Temporary Incapacity (TI) register as a complementary system to traditional epidemiological surveillance during the COVID-19 pandemic in Spain.
    PLoS One. 2024;19:e0301344.
    PubMed         Abstract available
  87. THANONGSAKSRIKUL J, Sritipsukho P, Srimanote P, Khantisitthiporn O, et al
    Characterization of antibody response to SARS-CoV-2 Orf8 from three waves of COVID-19 outbreak in Thailand.
    PLoS One. 2024;19:e0297272.
    PubMed         Abstract available
  88. LIU M, Yang W, Tian T, Yang J, et al
    Extreme value analysis of the number of student absences in Jiangsu, China: Based on extreme value theory.
    PLoS One. 2024;19:e0302360.
    PubMed         Abstract available
  89. HUAYTA VMR, Pradeilles R, Creed-Kanashiro HM, Rousham E, et al
    Identifying priority double-duty actions to tackle the double burden of malnutrition in infants and young children in Peru: Assessment and prioritisation of government actions by national experts.
    PLoS One. 2024;19:e0303668.
    PubMed         Abstract available
  90. JOHNSON KJ, O’Connell CP, Waken RJ, Barnes JM, et al
    Impact of COVID-19 pandemic on breast cancer screening in a large midwestern United States academic medical center.
    PLoS One. 2024;19:e0303280.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A
  91. LICHAND G, Doria CA
    The lasting impacts of remote learning in the absence of remedial policies: Evidence from Brazil.
    Proc Natl Acad Sci U S A. 2024;121:e2316300121.
    PubMed         Abstract available
  92. LAL A, Thompson DM
    Did private election administration funding advantage Democrats in 2020?
    Proc Natl Acad Sci U S A. 2024;121:e2317563121.
    PubMed         Abstract available
  93. ENDEVELT K, Halperin E, Porat R
    Zoom out: An intervention on the virtual learning environment improves minority students’ grades in two field experiments in Israel.
    Proc Natl Acad Sci U S A. 2024;121:e2313496121.
    PubMed         Abstract available
  94. MEI M, Cupic A, Miorin L, Ye C, et al
    Inhibition of mRNA nuclear export promotes SARS-CoV-2 pathogenesis.
    Proc Natl Acad Sci U S A. 2024;121:e2314166121.
    PubMed         Abstract available


    Vaccine
  95. BENEDICT KPOZEHOUEN E, Raina Macintyre C, Tan TC
    Coverage of influenza, pneumococcal and zoster vaccination and determinants of influenza and pneumococcal vaccination among adults with cardiovascular diseases in community.
    Vaccine. 2024 May 23:S0264-410X(24)00619-4. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  96. EIBERG MF, Rezahosseini O, Bukan KB, Charlotte Arp B, et al
    Changes in vaccination uptake against pneumococcal disease, influenza, and coronavirus disease 2019 (COVID-19) before and after a Head and Neck cancer diagnosis.
    Vaccine. 2024 May 23:S0264-410X(24)00566-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  97. ZHANG WX, Zhang Y, Du J, Shi W, et al
    Effectiveness of momentary intervention on influenza vaccination among the elderly in China: From willingness to action.
    Vaccine. 2024 May 22:S0264-410X(24)00591-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  98. VAN DER PLAS JL, Haijema BJ, Leenhouts K, Paul Zoeteweij J, et al
    Safety, reactogenicity and immunogenicity of an intranasal seasonal influenza vaccine adjuvanted with gram-positive matrix (GEM) particles (FluGEM): A randomized, double-blind, controlled, ascending dose study in healthy adults and elderly.
    Vaccine. 2024 May 20:S0264-410X(24)00370-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  99. YANG T, Tong F, Tang L, Li P, et al
    Repeated vaccination does not appear to significantly weaken the protective effect of influenza vaccine in the elderly: A test-negative case-control study in China.
    Vaccine. 2024 May 17:S0264-410X(24)00593-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  100. HU H, Ma F, Gong L, Wang Y, et al
    Immunogenicity and safety of a recombinant Omicron BA.4/5-Delta COVID-19 vaccine ZF2202-A in Chinese adults.
    Vaccine. 2024 May 3:S0264-410X(24)00495-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  101. NIESSEN FA, Bruijning-Verhagen PCJL, Bonten MJM, Knol MJ, et al
    Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands by medical risk condition: A test-negative case-control study.
    Vaccine. 2024 Apr 29:S0264-410X(24)00432-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  102. GUDOORU K, Nguyen K, Le K, Sarabu V, et al
    Collective good and individual choice: Perceptions on COVID-19 vaccine mandate among COVID-19 vaccinated individuals.
    Vaccine. 2024 Apr 27:S0264-410X(24)00479-1. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  103. LYTRAS T, Athanasiadou M, Demetriou A, Stylianou D, et al
    Authors’ reply: Excess mortality in Cyprus during the COVID-19 vaccination campaign.
    Vaccine. 2024 Apr 25:S0264-410X(24)00506-1. doi: 10.1016/j.vaccine.2024.
    PubMed        
  104. FUJITA DM, da Silva Nali LH, da Costa RR, de Andrade Junior HF, et al
    Low vaccine coverage and varicella outbreaks in Brazil – 2019-2022.
    Vaccine. 2024 Apr 24:S0264-410X(24)00435-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  105. SONG S, Madewell ZJ, Liu M, Miao Y, et al
    A systematic review and meta-analysis on the effectiveness of bivalent mRNA booster vaccines against Omicron variants.
    Vaccine. 2024 Apr 22:S0264-410X(24)00476-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  106. MUSA S, Merdrignac L, Skocibusic S, Nedic R, et al
    BBIBP-CorV vaccine effectiveness against COVID-19 in patients aged 60 years and older during the Delta-dominant period in the Federation of Bosnia and Herzegovina, a test-negative case-control study.
    Vaccine. 2024 Apr 20:S0264-410X(24)00471-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  107. RICKE IJ, Spaulding AB, Rajtar NN, Benton EM, et al
    Predictors of willingness to receive updated 2023-2024 COVID-19 booster vaccines among a convenience sample in Minnesota.
    Vaccine. 2024 Apr 18:S0264-410X(24)00480-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  108. ORANGZEB S, Desalegn A, Trinh NTH, Zhao J, et al
    COVID-19 vaccine uptake among children and adolescents in Norway: A comprehensive registry-based cohort study of over 800,000 individuals.
    Vaccine. 2024 Apr 18:S0264-410X(24)00464-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  109. TRINITE B, Durr E, Pons-Grifols A, O’Donnell G, et al
    VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice.
    Vaccine. 2024 Apr 18:S0264-410X(24)00473-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  110. KUPEK E
    Avoidable COVID-19-related deaths and hospitalizations in Brazil, 2020-2023.
    Vaccine. 2024;42:3437-3444.
    PubMed         Abstract available
  111. ECONOMIDOU EC, Soteriades ES
    Excess mortality in Cyprus during the COVID-19 vaccination campaign.
    Vaccine. 2023 Nov 22:S0264-410X(23)01361-0. doi: 10.1016/j.vaccine.2023.
    PubMed        
  112. BOLOTIN S, Osman S, Halperin S, Severini A, et al
    Immunity of Canadians and risk of epidemics workshop – Conference report.
    Vaccine. 2023;41:6775-6781.
    PubMed         Abstract available
  113. PARK H, Jang MS, Choi JA, Kim W, et al
    Nonclinical safety assessment and immunogenicity of rVSVInd(GML)-mspSGtc vaccine for SARS-CoV-2 in rabbits.
    Vaccine. 2023 Oct 9:S0264-410X(23)01178-7. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
  114. MO C, Li X, Wu Q, Fan Y, et al
    SARS-CoV-2 mRNA vaccine requires signal peptide to induce antibody responses.
    Vaccine. 2023 Oct 9:S0264-410X(23)01156-8. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
  115. PROCTER TD, Ogasawara H, Spruin S, Wijayasri S, et al
    Thrombosis with thrombocytopenia syndrome (TTS) following adenovirus vector COVID-19 vaccination in Canada.
    Vaccine. 2023 Oct 6:S0264-410X(23)01159-3. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
  116. DO LAH, Le NTN, Mahmud S, Mulholland K, et al
    Impact and cost-effectiveness of strategies to prevent respiratory syncytial virus (RSV) disease in Vietnam: A modelling study.
    Vaccine. 2023;41:6782-6790.
    PubMed         Abstract available


    Virus Res
  117. LIN X, Yang F, Yan S, Wu H, et al
    Preparation and characterization of mouse-derived monoclonal antibodies against the hemagglutinin of the H1N1 influenza virus.
    Virus Res. 2024;345:199402.
    PubMed         Abstract available

#Coronavirus Disease Research #References (by AMEDEO, May 18 ’24)

  1. MATTHAY MA, Ware LB, Riviello ED, Wick KD, et al
    Reply to Liufu et al. and to Palanidurai et al.
    Am J Respir Crit Care Med. 2024;209:1280.
    PubMed        


    Antiviral Res
  2. HUANG J, Wang W, Li H, Bai Y, et al
    Three in one: An effective and universal vaccine expressing heterologous tandem RBD trimer by rabies virus vector protects mice against SARS-CoV-2.
    Antiviral Res. 2024;227:105905.
    PubMed         Abstract available
  3. PANDEY K, Acharya A, Pal D, Jain P, et al
    SRX3177, a CDK4/6-PI3K-BET inhibitor, in combination with an RdRp inhibitor, Molnupiravir, or an entry inhibitor MU-UNMC-2, has potent antiviral activity against the Omicron variant of SARS-CoV-2.
    Antiviral Res. 2024;227:105904.
    PubMed         Abstract available


    BMJ
  4. LOOI MK
    Sixty seconds on . . . Apple Watch.
    BMJ. 2024;385:q1063.
    PubMed        
  5. O’CONNOR RJ, Parkin A, Mir G, Mullard J, et al
    Work and vocational rehabilitation for people living with long covid.
    BMJ. 2024;385:e076508.
    PubMed        
  6. MAHASE E
    Infective endocarditis: Coroner’s report questions NICE guidance on prevention.
    BMJ. 2024;385:q1081.
    PubMed        
  7. NAKWEYA G
    Doctors in Kenya end strike after threat of court action.
    BMJ. 2024;385:q1088.
    PubMed        
  8. LANG K
    What do we know about covid-19’s effects on the brain?
    BMJ. 2024;385:q897.
    PubMed        

  9. Seven days in medicine: 8-14 May 2024.
    BMJ. 2024;385:q1079.
    PubMed        
  10. NOGRADY B
    Australia: Inductions and preterm births fell during early pandemic years.
    BMJ. 2024;385:q1112.
    PubMed        
  11. MAHASE E
    Hospitals are urged to increase use of virtual wards to cut admissions.
    BMJ. 2024;385:q1123.
    PubMed        
  12. WISE J
    Sixty seconds on . . . the pandemic treaty.
    BMJ. 2024;385:q1124.
    PubMed        


    Clin Infect Dis
  13. LEE TC, Boulware DR
    Is there room for metformin at COVID-19’s dinner table? Updated Analysis of Clinical Trials.
    Clin Infect Dis. 2024 May 17:ciae284. doi: 10.1093.
    PubMed        
  14. RABIN AS, Marr LC, Blumberg HM
    Doff Thy Gown – Shedding Contact Precautions for COVID-19.
    Clin Infect Dis. 2024 May 15:ciae276. doi: 10.1093.
    PubMed         Abstract available
  15. CASADEVALL A, Focosi D
    Anti-Spike monoclonal antibody monotherapies and immune escape risk minimization strategies.
    Clin Infect Dis. 2024 May 13:ciae254. doi: 10.1093.
    PubMed        
  16. SCHMITT SK
    IDSA’s Letter to the American Board of Internal Medicine.
    Clin Infect Dis. 2024;78:1099-1100.
    PubMed        
  17. LEE MSL
    The Pandemic Babies.
    Clin Infect Dis. 2024;78:1088-1089.
    PubMed        
  18. HAMILL M, Ghanem KG, Tuddenham S
    Reply to: Cortes-Penfield and Musher.
    Clin Infect Dis. 2024;78:1387-1388.
    PubMed        


    Infect Control Hosp Epidemiol
  19. CHOW EJ, Lee L, Lenahan J, Pogosjans S, et al
    Community respiratory viral metrics to inform masking in healthcare settings: A regional consensus approach.
    Infect Control Hosp Epidemiol. 2024;45:793-795.
    PubMed        


    Int J Infect Dis
  20. BOJJA D, Zuo S, Townsend JP
    Sufficient COVID-19 quarantine and testing on international travelers to forestall cross-border transmission after China’s removal of the Zero-COVID policy in early 2023.
    Int J Infect Dis. 2024 May 13:107097. doi: 10.1016/j.ijid.2024.107097.
    PubMed         Abstract available
  21. VAZQUEZ E, de Gregorio-Vicente O, Soriano V, Alvarez-Dominguez C, et al
    Increased incidence and mortality from Listeria monocytogenes infection in Spain.
    Int J Infect Dis. 2024 May 9:107089. doi: 10.1016/j.ijid.2024.107089.
    PubMed         Abstract available
  22. KYI D, Xiao Y, Wang X, Feng S, et al
    Predominance of A2063G mutant strains in the Mycoplasma pneumoniae epidemic in children-a clinical and epidemiological study in 2023 in Wuhan, China.
    Int J Infect Dis. 2024 May 9:107074. doi: 10.1016/j.ijid.2024.107074.
    PubMed         Abstract available


    J Infect
  23. YANG X, Li X, Qiu S, Liu C, et al
    Global antimicrobial resistance and antibiotic use in COVID-19 patients within health facilities: a systematic review and meta-analysis of aggregated participant data.
    J Infect. 2024 May 14:106183. doi: 10.1016/j.jinf.2024.106183.
    PubMed         Abstract available
  24. AMANO M, Ichikawa Y, Matsumoto S, Higashi-Kuwata N, et al
    Neutralization activity of HCWs’ sera after Omicron XBB.1.5-adapted monovalent COVID-19 mRNA vaccination.
    J Infect. 2024;89:106179.
    PubMed        
  25. PANG CWK, Vale R, Lao KS, Khan AT, et al
    Increased Incidence of Invasive Pneumococcal Disease in Hong Kong in 2023.
    J Infect. 2024 May 11:106178. doi: 10.1016/j.jinf.2024.106178.
    PubMed         Abstract available


    J Med Virol
  26. KYUNG S, Son Y, Kim M, Kang J, et al
    Risks of alopecia areata in long COVID: Binational population-based cohort studies from South Korea and Japan.
    J Med Virol. 2024;96:e29668.
    PubMed         Abstract available
  27. FERNANDEZ-DE-LAS-PENAS C, Torres-Macho J, Ruiz-Ruigomez M, Arrieta-Ortubay E, et al
    Presence of SARS-CoV-2 RNA in COVID-19 survivors with post-COVID symptoms 2 years after hospitalization: The VIPER study.
    J Med Virol. 2024;96:e29676.
    PubMed         Abstract available
  28. QIAO H, Deng X, Qiu L, Qu Y, et al
    SARS-CoV-2 induces blood-brain barrier and choroid plexus barrier impairments and vascular inflammation in mice.
    J Med Virol. 2024;96:e29671.
    PubMed         Abstract available
  29. DAMODAR T, Dunai C, Prabhu N, Jose M, et al
    Diagnostic markers of acute encephalitis syndrome and COVID-associated multisystem inflammatory syndrome in children from Southern India.
    J Med Virol. 2024;96:e29666.
    PubMed         Abstract available


    J Virol
  30. CESAR RAMOS DE JESUS H, Solis N, Machado Y, Pablos I, et al
    Optimization of quenched fluorescent peptide substrates of SARS-CoV-2 3CL(pro) main protease (Mpro) from proteomic identification of P6-P6′ active site specificity.
    J Virol. 2024 May 14:e0004924. doi: 10.1128/jvi.00049.
    PubMed         Abstract available


    JAMA
  31. RUBIN R
    Combined Vaccines Against COVID-19, Flu, and Other Respiratory Illnesses Could Soon Be Available.
    JAMA. 2024 May 17. doi: 10.1001/jama.2024.7370.
    PubMed        
  32. XIE Y, Choi T, Al-Aly Z
    Mortality in Patients Hospitalized for COVID-19 vs Influenza in Fall-Winter 2023-2024.
    JAMA. 2024 May 15:e247395. doi: 10.1001/jama.2024.7395.
    PubMed        

  33. Audio Highlights.
    JAMA. 2024;331:e2318283.
    PubMed        
  34. CHESHIRE WP, Dudenkov DV, Munipalli B
    Tilt Table Testing.
    JAMA. 2024;331:1494-1495.
    PubMed        


    Lancet
  35. WATTS G
    Alasdair Macintosh Geddes.
    Lancet. 2024;403:1846.
    PubMed        
  36. AUJLA M
    Art, plunder, fragile fault lines.
    Lancet. 2024;403:1844-1845.
    PubMed        
  37. USHER AD
    Organisations vie for control over pandemic financing.
    Lancet. 2024;403:1839-1840.
    PubMed        
  38. GREENHALGH T, MacIntyre CR, Ungrin M, Wright JM, et al
    Airborne pathogens: controlling words won’t control transmission.
    Lancet. 2024;403:1850-1851.
    PubMed        
  39. KNUPPEL A, Boyd A, Macleod J, Chaturvedi N, et al
    The long COVID evidence gap in England.
    Lancet. 2024 May 6:S0140-6736(24)00744-X. doi: 10.1016/S0140-6736(24)00744.
    PubMed        
  40. YANG YT
    Protecting humanitarian aid workers: an urgent call.
    Lancet. 2024;403:1847.
    PubMed        
  41. ABUZERR S, Zinser K
    Amplifying the voices of women in the Gaza Strip.
    Lancet. 2024;403:1848-1849.
    PubMed        


    N Engl J Med
  42. SCHUBACH A, Ricotta D, Kittleson MM
    To Preround or Not to Preround.
    N Engl J Med. 2024;390:1824-1826.
    PubMed        
  43. YANG C, Espin E, Tebbutt SJ
    False Positive Covid-19 Rapid Antigen Tests.
    N Engl J Med. 2024;390:1835-1836.
    PubMed        
  44. HERBERT C, McManus DD, Soni A
    False Positive Covid-19 Rapid Antigen Tests. Reply.
    N Engl J Med. 2024;390:1836.
    PubMed        


    Nature
  45. NORDLING L
    Why my heart beats for Nigeria’s endangered bats.
    Nature. 2024;629:720.
    PubMed        
  46. KOZLOV M
    US funders to tighten oversight of controversial ‘gain of function’ research.
    Nature. 2024;629:510-511.
    PubMed        
  47. LIANG CY, Raju S, Liu Z, Li Y, et al
    Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines.
    Nature. 2024 May 15. doi: 10.1038/s41586-024-07539.
    PubMed         Abstract available
  48. LENHARO M
    US halts funding to controversial virus-hunting group: what researchers think.
    Nature. 2024 May 16. doi: 10.1038/d41586-024-01460.
    PubMed        

#Influenza and Other Respiratory #Pathogens Research #References (by AMEDEO, May 18 ’24)

  1. ASADIPOOYA K, Asadipooya A, Adatorwovor R
    Combination of spironolactone and DPP-4 inhibitors for treatment of SARS-CoV-2 infection: a literature review.
    Arch Virol. 2024;169:122.
    PubMed         Abstract available


    Biochem Biophys Res Commun
  2. KULMA M, Sakanovic A, Bedina-Zavec A, Caserman S, et al
    Sequestration of membrane cholesterol by cholesterol-binding proteins inhibits SARS-CoV-2 entry into Vero E6 cells.
    Biochem Biophys Res Commun. 2024;716:149954.
    PubMed         Abstract available


    BMC Pediatr
  3. AL-IEDE M, Alhouri A, Marwa K, Alnajjar R, et al
    Respiratory syncytial virus in pediatric patients admitted to a tertiary center in Amman: clinical characteristics, and age-related patterns.
    BMC Pediatr. 2024;24:334.
    PubMed         Abstract available
  4. JIANG Z, Fang C, Peng F, Fan W, et al
    Comparison of clinical characteristics and disease burden of febrile seizures in children with and without COVID-19.
    BMC Pediatr. 2024;24:329.
    PubMed         Abstract available
  5. HUANG L, Ye C, Zhou R, Ji Z, et al
    Diagnostic value of routine blood tests in differentiating between SARS-CoV-2, influenza A, and RSV infections in hospitalized children: a retrospective study.
    BMC Pediatr. 2024;24:328.
    PubMed         Abstract available


    BMJ
  6. WISE J
    Sixty seconds on . . . the pandemic treaty.
    BMJ. 2024;385:q1124.
    PubMed        
  7. MAHASE E
    Hospitals are urged to increase use of virtual wards to cut admissions.
    BMJ. 2024;385:q1123.
    PubMed        
  8. NOGRADY B
    Australia: Inductions and preterm births fell during early pandemic years.
    BMJ. 2024;385:q1112.
    PubMed        

  9. Seven days in medicine: 8-14 May 2024.
    BMJ. 2024;385:q1079.
    PubMed        
  10. LANG K
    What do we know about covid-19’s effects on the brain?
    BMJ. 2024;385:q897.
    PubMed        
  11. NAKWEYA G
    Doctors in Kenya end strike after threat of court action.
    BMJ. 2024;385:q1088.
    PubMed        
  12. MAHASE E
    Infective endocarditis: Coroner’s report questions NICE guidance on prevention.
    BMJ. 2024;385:q1081.
    PubMed        
  13. O’CONNOR RJ, Parkin A, Mir G, Mullard J, et al
    Work and vocational rehabilitation for people living with long covid.
    BMJ. 2024;385:e076508.
    PubMed        
  14. LOOI MK
    Sixty seconds on . . . Apple Watch.
    BMJ. 2024;385:q1063.
    PubMed        


    Cell
  15. HARTMANN JA, Cardoso MR, Talarico MCR, Kenney DJ, et al
    Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses.
    Cell. 2024;187:2393-2410.
    PubMed         Abstract available


    Drugs
  16. ZHU C, Pang S, Liu J, Duan Q, et al
    Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines.
    Drugs. 2024;84:403-423.
    PubMed         Abstract available


    Epidemiol Infect
  17. PARK JO, Cho HK, Jeon CH, Kim SH, et al
    Characteristics and biomarkers associated with mortality in COVID-19 patients presenting to the emergency department.
    Epidemiol Infect. 2024;152:e76.
    PubMed         Abstract available


    J Infect Dis
  18. MOTSOENENG BM, Dhar N, Nunes MC, Krammer F, et al
    Hemagglutinin stalk-specific Fc-mediated functions are associated with protection against influenza-illness after seasonal influenza vaccination in pregnant women.
    J Infect Dis. 2024 May 14:jiae241. doi: 10.1093.
    PubMed         Abstract available
  19. BEN MAMOUN C, Vydyam P
    Response to the Letter by Liu and Colleagues.
    J Infect Dis. 2024;229:1601.
    PubMed        
  20. FOTOOH ABADI L, Sharma MB, Kelesidis T
    Single-Cell Profiling of the Differential In Vivo Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Lung Tissue Cell Subtypes at the Protein Level.
    J Infect Dis. 2024;229:1382-1386.
    PubMed         Abstract available
  21. WONG M, Gain C, Sharma MB, Fotooh Abadi L, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Infection Alters Mediators of Lung Tissue Remodeling In Vitro and In Vivo.
    J Infect Dis. 2024;229:1372-1381.
    PubMed         Abstract available
  22. KARABA AH, Morgenlander WR, Johnston TS, Hage C, et al
    Epitope Mapping of SARS-CoV-2 Spike Antibodies in Vaccinated Kidney Transplant Recipients Reveals Poor Spike Coverage Compared to Healthy Controls.
    J Infect Dis. 2023 Nov 29:jiad534. doi: 10.1093.
    PubMed         Abstract available
  23. DOS RAMOS ALMEIDA CJL, Veras FP, Paiva IM, Schneider AH, et al
    Neutrophil Virucidal Activity Against SARS-CoV-2 Is Mediated by Neutrophil Extracellular Traps.
    J Infect Dis. 2024;229:1352-1365.
    PubMed         Abstract available
  24. LEDUCQ V, Zafilaza K, Fauchois A, Ghidaoui E, et al
    Spike Protein Genetic Evolution in Patients at High Risk of Severe Coronavirus Disease 2019 Treated by Monoclonal Antibodies.
    J Infect Dis. 2024;229:1341-1351.
    PubMed         Abstract available
  25. HAIDAR G, Hodges JC, Bilderback A, Lukanski A, et al
    Prospective assessment of humoral and cellular immune responses to a 3rd COVID-19 mRNA vaccine dose among immunocompromised individuals.
    J Infect Dis. 2023 Nov 16:jiad511. doi: 10.1093.
    PubMed         Abstract available


    J Virol
  26. MEADE PS, Bandawane P, Bushfield K, Hoxie I, et al
    Detection of clade 2.3.4.4b highly pathogenic H5N1 influenza virus in New York City.
    J Virol. 2024 May 15:e0062624. doi: 10.1128/jvi.00626.
    PubMed         Abstract available
  27. VIOX EG, Bosinger SE, Douek DC, Schreiber G, et al
    Harnessing the power of IFN for therapeutic approaches to COVID-19.
    J Virol. 2024 Apr 23:e0120423. doi: 10.1128/jvi.01204.
    PubMed         Abstract available
  28. MAO D, Liu S, Phan AT, Renner S, et al
    The TRAF3-DYRK1A-RAD54L2 complex maintains ACE2 expression to promote SARS-CoV-2 infection.
    J Virol. 2024 Apr 23:e0034724. doi: 10.1128/jvi.00347.
    PubMed         Abstract available
  29. HAN Y, Yuan Z, Yi Z
    Identification of a membrane-associated element (MAE) in the C-terminal region of SARS-CoV-2 nsp6 that is essential for viral replication.
    J Virol. 2024 Apr 19:e0034924. doi: 10.1128/jvi.00349.
    PubMed         Abstract available
  30. PEREZ DR
    A devastating blow: personal reflections on Argentina’s scientific decline.
    J Virol. 2024 Apr 16:e0054924. doi: 10.1128/jvi.00549.
    PubMed         Abstract available
  31. ISHIMARU H, Nishimura M, Shigematsu H, Marini MI, et al
    Epitopes of an antibody that neutralizes a wide range of SARS-CoV-2 variants in a conserved subdomain 1 of the spike protein.
    J Virol. 2024 Apr 16:e0041624. doi: 10.1128/jvi.00416.
    PubMed         Abstract available
  32. TAKADA K, Orba Y, Kida Y, Wu J, et al
    Genes involved in the limited spread of SARS-CoV-2 in the lower respiratory airways of hamsters may be associated with adaptive evolution.
    J Virol. 2024 Apr 16:e0178423. doi: 10.1128/jvi.01784.
    PubMed         Abstract available
  33. BOON ACM, Bricker TL, Fritch EJ, Leist SR, et al
    Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19.
    J Virol. 2024 Apr 9:e0190323. doi: 10.1128/jvi.01903.
    PubMed         Abstract available
  34. YANG R, Han P, Han P, Li D, et al
    Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2.
    J Virol. 2024 Apr 9:e0045124. doi: 10.1128/jvi.00451.
    PubMed         Abstract available
  35. XIAO X, Fu Y, You W, Huang C, et al
    Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide.
    J Virol. 2024 Apr 4:e0157323. doi: 10.1128/jvi.01573.
    PubMed         Abstract available
  36. BRUNET J, Choucha Z, Gransagne M, Tabbal H, et al
    A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.
    J Virol. 2024 Apr 2:e0169323. doi: 10.1128/jvi.01693.
    PubMed         Abstract available
  37. NAMBULLI S, Escriou N, Rennick LJ, Demers MJ, et al
    A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease.
    J Virol. 2024 Apr 2:e0176223. doi: 10.1128/jvi.01762.
    PubMed         Abstract available


    JAMA
  38. XIE Y, Choi T, Al-Aly Z
    Mortality in Patients Hospitalized for COVID-19 vs Influenza in Fall-Winter 2023-2024.
    JAMA. 2024 May 15:e247395. doi: 10.1001/jama.2024.7395.
    PubMed        

  39. Audio Highlights.
    JAMA. 2024;331:e2318283.
    PubMed        
  40. CHESHIRE WP, Dudenkov DV, Munipalli B
    Tilt Table Testing.
    JAMA. 2024;331:1494-1495.
    PubMed        


    Lancet
  41. KOJIMA N, Adlhoch C, Mitja O, Dat VQ, et al
    Building global preparedness for avian influenza.
    Lancet. 2024 May 9:S0140-6736(24)00934-6. doi: 10.1016/S0140-6736(24)00934.
    PubMed        
  42. WATTS G
    Alasdair Macintosh Geddes.
    Lancet. 2024;403:1846.
    PubMed        
  43. AUJLA M
    Art, plunder, fragile fault lines.
    Lancet. 2024;403:1844-1845.
    PubMed        
  44. USHER AD
    Organisations vie for control over pandemic financing.
    Lancet. 2024;403:1839-1840.
    PubMed        
  45. GREENHALGH T, MacIntyre CR, Ungrin M, Wright JM, et al
    Airborne pathogens: controlling words won’t control transmission.
    Lancet. 2024;403:1850-1851.
    PubMed        
  46. YANG YT
    Protecting humanitarian aid workers: an urgent call.
    Lancet. 2024;403:1847.
    PubMed        
  47. ABUZERR S, Zinser K
    Amplifying the voices of women in the Gaza Strip.
    Lancet. 2024;403:1848-1849.
    PubMed        


    N Engl J Med
  48. HERBERT C, McManus DD, Soni A
    False Positive Covid-19 Rapid Antigen Tests. Reply.
    N Engl J Med. 2024;390:1836.
    PubMed        
  49. YANG C, Espin E, Tebbutt SJ
    False Positive Covid-19 Rapid Antigen Tests.
    N Engl J Med. 2024;390:1835-1836.
    PubMed        
  50. SCHUBACH A, Ricotta D, Kittleson MM
    To Preround or Not to Preround.
    N Engl J Med. 2024;390:1824-1826.
    PubMed        


    PLoS Comput Biol
  51. LOPEZ VK, Cramer EY, Pagano R, Drake JM, et al
    Challenges of COVID-19 Case Forecasting in the US, 2020-2021.
    PLoS Comput Biol. 2024;20:e1011200.
    PubMed         Abstract available
  52. ASPLIN P, Keeling MJ, Mancy R, Hill EM, et al
    Epidemiological and health economic implications of symptom propagation in respiratory pathogens: A mathematical modelling investigation.
    PLoS Comput Biol. 2024;20:e1012096.
    PubMed         Abstract available


    PLoS One
  53. BRETANA NA, Kwon JA, Grant L, Galouzis J, et al
    Controlling COVID-19 outbreaks in the correctional setting: A mathematical modelling study.
    PLoS One. 2024;19:e0303062.
    PubMed         Abstract available
  54. SHERAK RAG, Sajjadi H, Khimani N, Tolchin B, et al
    SOFA score performs worse than age for predicting mortality in patients with COVID-19.
    PLoS One. 2024;19:e0301013.
    PubMed         Abstract available
  55. THAMPI N, Burhunduli T, Strain J, Raudanskis A, et al
    Detection of SARS-CoV-2 in schools using built environment testing in Ottawa, Canada: A multi-facility prospective surveillance study.
    PLoS One. 2024;19:e0300397.
    PubMed         Abstract available
  56. HARRIS J, Germain J, McCoy E, Schofield R, et al
    Ethical guidance for conducting health research with online communities: A scoping review of existing guidance.
    PLoS One. 2024;19:e0302924.
    PubMed         Abstract available
  57. FENG W, Zhao L, Ge Z, Zhao X, et al
    Association between physical activity and adolescent mental health in the post COVID-19: The chain mediating effect of self-esteem and social anxiety.
    PLoS One. 2024;19:e0301617.
    PubMed         Abstract available
  58. ESPOSITO G, Hunashal Y, Percipalle M, Fogolari F, et al
    Assessing nanobody interaction with SARS-CoV-2 Nsp9.
    PLoS One. 2024;19:e0303839.
    PubMed         Abstract available
  59. GUNAY-POLATKAN S, Caliskan S, Sigirli D
    Association of atherogenic indices with myocardial damage and mortality in COVID-19.
    PLoS One. 2024;19:e0302984.
    PubMed         Abstract available
  60. PANAHI R, Ghorbanpour Z, Moradi B, Eidy F, et al
    The relationship between health literacy and the adoption of COVID-19 preventive behaviors: A cross-sectional study in Iran.
    PLoS One. 2024;19:e0299007.
    PubMed         Abstract available
  61. UMEH GC, Cleenwerck de Kiev L, Mamza J, Atiku A, et al
    Symptoms of depression among outpatients with suspected COVID-19 in metropolitan Local Government Areas of Kaduna State, Nigeria.
    PLoS One. 2024;19:e0288567.
    PubMed         Abstract available
  62. URAZAYEVA ST, Kurmangaliyeva SS, Kaliyev AA, Tussupkaliyeva KS, et al
    Attitude toward vaccination against COVID-19 and acceptance of the national “QazVac” vaccine in the Aktobe city population, West Kazakhstan: A cross-sectional survey.
    PLoS One. 2024;19:e0303854.
    PubMed         Abstract available
  63. ZHOU Q, Zhao G, Pan Y, Zhang Y, et al
    The efficacy and safety of fluvoxamine in patients with COVID-19: A systematic review and meta-analysis from randomized controlled trials.
    PLoS One. 2024;19:e0300512.
    PubMed         Abstract available
  64. SHYU D, Bliss P, Adams A, Cho RJ, et al
    Development and performance evaluation of a solenoid valve assisted low-cost ventilator on gas exchange and respiratory mechanics in a porcine model.
    PLoS One. 2024;19:e0303443.
    PubMed         Abstract available
  65. DUNCAN G, Christensen WF, Handley C
    COVID-19 hotspot detection in a university setting.
    PLoS One. 2024;19:e0289254.
    PubMed         Abstract available
  66. OLIVEIRA ES, Nascimento ALBD, Ferreira Junior WS, Albuquerque UP, et al
    How does prestige bias affect information recall during a pandemic?
    PLoS One. 2024;19:e0303512.
    PubMed         Abstract available
  67. KHALIL B, Sharif-Askari NS, Hafezi S, Sharif-Askari FS, et al
    Vitamin D regulates COVID-19 associated severity by suppressing the NLRP3 inflammasome pathway.
    PLoS One. 2024;19:e0302818.
    PubMed         Abstract available
  68. KASPERSKA A, Matysiak A, Cukrowska-Torzewska E
    Managerial (dis)preferences towards employees working from home: Post-pandemic experimental evidence.
    PLoS One. 2024;19:e0303307.
    PubMed         Abstract available
  69. PARK J, Joo H, Kim D, Mase S, et al
    Cost-effectiveness of mask mandates on subways to prevent SARS-CoV-2 transmission in the United States.
    PLoS One. 2024;19:e0302199.
    PubMed         Abstract available
  70. BISHOP-EDWARDS L, Taylor Buck E, Weich S
    The delivery of creative socially prescribed activities for people with serious mental health needs during lockdown: Learning about remote, digital and hybrid delivery.
    PLoS One. 2024;19:e0301550.
    PubMed         Abstract available
  71. BABAR M, Qureshi B, Koubaa A
    Investigating the impact of data heterogeneity on the performance of federated learning algorithm using medical imaging.
    PLoS One. 2024;19:e0302539.
    PubMed         Abstract available
  72. HUNTER PR, Brainard J
    Changing risk factors for developing SARS-CoV-2 infection from Delta to Omicron.
    PLoS One. 2024;19:e0299714.
    PubMed         Abstract available
  73. ARGENIO KL, Day SE, D’Agostino EM, Neshteruk C, et al
    Increasing disparities in obesity and severe obesity prevalence among public elementary and middle school students in New York City, school years 2011-12 through 2019-20.
    PLoS One. 2024;19:e0302099.
    PubMed         Abstract available
  74. XU W, Bao X, Lou X, Liu X, et al
    Feature fusion method for pulmonary tuberculosis patient detection based on cough sound.
    PLoS One. 2024;19:e0302651.
    PubMed         Abstract available
  75. KHEZRI M, McKnight C, Weng CA, Kimball S, et al
    COVID-19 vaccination uptake and determinants of booster vaccination among persons who inject drugs in New York City.
    PLoS One. 2024;19:e0303394.
    PubMed         Abstract available
  76. YANG Q, Chang A, Tong X, Jackson SL, et al
    Long-term cardiovascular disease outcomes in non-hospitalized medicare beneficiaries diagnosed with COVID-19: Population-based matched cohort study.
    PLoS One. 2024;19:e0302593.
    PubMed         Abstract available
  77. NHACOLO A, Magaco A, Amosse F, Hunguana A, et al
    Perceptions and compliance with COVID-19 preventive measures in Southern and Central regions of Mozambique: A quantitative in-person household survey in the districts of Manhica and Quelimane.
    PLoS One. 2024;19:e0278439.
    PubMed         Abstract available
  78. WANG B, Tong C, Chen T, Yang J, et al
    Evaluation of China’s live streaming e-commerce industry policies based on a three-dimensional analysis framework.
    PLoS One. 2024;19:e0301451.
    PubMed         Abstract available
  79. WASSIE GT, Ambelie YA, Adebabay T, Yeshiwas AG, et al
    Covid-19 vaccine uptake and its associated factors among adult population in Dangila district, Awi Zone, Northwest Ethiopia: A mixed method study.
    PLoS One. 2024;19:e0302531.
    PubMed         Abstract available
  80. MEYER D, Lowensen K, Perrin N, Moore A, et al
    An evaluation of the impact of social and structural determinants of health on forgone care during the COVID-19 pandemic in Baltimore, Maryland.
    PLoS One. 2024;19:e0302064.
    PubMed         Abstract available
  81. FUKUYAMA K, Mori Y, Ueshima H, Ito S, et al
    Medical resource usage for COVID-19 evaluated using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
    PLoS One. 2024;19:e0303493.
    PubMed         Abstract available
  82. YASEEN A, DeSantis SM, Sabharwal R, Talebi Y, et al
    Baseline characteristics of SARS-CoV-2 vaccine non-responders in a large population-based sample.
    PLoS One. 2024;19:e0303420.
    PubMed         Abstract available
  83. GAO Y, Ma Y, Li Y, Zhao Y, et al
    Prevalence and correlates of mental disorders among Chinese overseas students during the COVID-19: A multi-regional cross-sectional analysis.
    PLoS One. 2024;19:e0303283.
    PubMed         Abstract available
  84. THOMAZELLI LM, Pinho JRR, Dorlass EG, Ometto T, et al
    Evidence of reassortment of avian influenza A (H2) viruses in Brazilian shorebirds.
    PLoS One. 2024;19:e0300862.
    PubMed         Abstract available
  85. BROWN RT, Zamora K, Rizzo A, Spar MJ, et al
    Improving measurement of functional status among older adults in primary care: A pilot study.
    PLoS One. 2024;19:e0303402.
    PubMed         Abstract available
  86. RYS M, Schollaert E, Van Hoye G
    Living the employer brand during a crisis? A qualitative study on internal employer branding in times of the COVID-19 pandemic.
    PLoS One. 2024;19:e0303361.
    PubMed         Abstract available
  87. SIMONSSON O, Fisher SD
    Mindfulness meditation use in Britain during the COVID-19 pandemic.
    PLoS One. 2024;19:e0303349.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A
  88. OTTER CJ, Renner DM, Fausto A, Tan LH, et al
    Interferon signaling in the nasal epithelium distinguishes among lethal and common cold coronaviruses and mediates viral clearance.
    Proc Natl Acad Sci U S A. 2024;121:e2402540121.
    PubMed         Abstract available
  89. KITAMURA S, Lin TH, Lee CD, Takamura A, et al
    Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry.
    Proc Natl Acad Sci U S A. 2024;121:e2310677121.
    PubMed         Abstract available
  90. XIE Y, Yang F, Huang J, He Y, et al
    Declining Chinese attitudes toward the United States amid COVID-19.
    Proc Natl Acad Sci U S A. 2024;121:e2322920121.
    PubMed         Abstract available


    Vaccine
  91. CARNALLA M, Stern D, Arantxa Colchero M, Rangel-Moreno K, et al
    Who is getting COVID-19 boosters? A latent class analysis in a nationally representative sample of Mexican adults 60 years and over.
    Vaccine. 2024;42:3273-3276.
    PubMed         Abstract available
  92. LIEVRE G, Sicsic J, Galmiche S, Charmet T, et al
    Are the 7C psychological antecedents associated with COVID-19 vaccine behaviours beyond intentions? A cross-sectional study on at-least-one-dose and up-to-date vaccination status, and uptake speed among adults in France.
    Vaccine. 2024 Apr 19:S0264-410X(24)00438-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  93. RAMOS-DUARTE VA, Orlowski A, Jaquenod de Giusti C, Corigliano MG, et al
    Safe plant Hsp90 adjuvants elicit an effective immune response against SARS-CoV2-derived RBD antigen.
    Vaccine. 2024;42:3355-3364.
    PubMed         Abstract available
  94. MELNIKOW J, Padovani A, Zhang J, Miller M, et al
    Patient concerns and physician strategies for addressing COVID-19 vaccine hesitancy.
    Vaccine. 2024 Apr 15:S0264-410X(24)00437-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  95. WONG IOL, Wong C, Mak N, Dai A, et al
    Assessment of the impact of the vaccine pass policy on COVID-19 vaccine hesitancy and uptake among Chinese adults in Hong Kong.
    Vaccine. 2024 Apr 15:S0264-410X(24)00449-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  96. SUKIK L, Chemaitelly H, Ayoub HH, Coyle P, et al
    Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient.
    Vaccine. 2024 Apr 13:S0264-410X(24)00440-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  97. LEE JS, Choi H, Shin SH, Hwang MJ, et al
    Characterization of Brighton Collaboration criteria for myocarditis and pericarditis following COVID-19 vaccine in Korean adolescents.
    Vaccine. 2024 Apr 11:S0264-410X(24)00446-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  98. THAI H, Audet EC, Koestner R
    Motivation for COVID-19 Vaccination: Applying a Self-Determination Theory Perspective to a Global Health Crisis.
    Vaccine. 2024 Apr 9:S0264-410X(24)00439-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


    Virology
  99. LEE J, Naoe Y, Bang U, Nakagama Y, et al
    Neutralization sensitivity of SARS-CoV-2 Omicron variants FL.1 and GE.1 by therapeutic antibodies and XBB sera.
    Virology. 2024;595:110067.
    PubMed         Abstract available
  100. GILLOT C, Tre-Hardy M, Cupaiolo R, Blairon L, et al
    Assessment of the neutralizing antibody response in Omicron breakthrough cases in healthcare workers who received the homologous booster of Moderna mRNA-1273.
    Virology. 2024;595:110082.
    PubMed         Abstract available
  101. UENO S, Amarbayasgalan S, Sugiura Y, Takahashi T, et al
    Eight-amino-acid sequence at the N-terminus of SARS-CoV-2 nsp1 is involved in stabilizing viral genome replication.
    Virology. 2024;595:110068.
    PubMed         Abstract available

#Coronavirus Disease Research #References (by AMEDEO, May 11 ’24)

  1. MONZON R, Ornelas-Dorian C, Eucker SA, Rising K, et al
    An evaluation of COVID-19 vaccine messaging platforms in the emergency department.
    Acad Emerg Med. 2024 May 5. doi: 10.1111/acem.14933.
    PubMed        


    Antiviral Res
  2. SALGADO-BENVINDO C, Tas A, Zevenhoven-Dobbe JC, van der Meer Y, et al
    Characterization of SARS-CoV-2 replication in human H1299/ACE2 cells: a versatile and practical infection model for antiviral research and beyond.
    Antiviral Res. 2024 May 7:105903. doi: 10.1016/j.antiviral.2024.105903.
    PubMed         Abstract available


    BMJ

  3. Seven days in medicine: 1-7 May 2024.
    BMJ. 2024;385:q1022.
    PubMed        
  4. MAHASE E
    Workforce and winter under Labour: Wes Streeting on his plan for the NHS and ending the strikes.
    BMJ. 2024;385:q992.
    PubMed        
  5. WONG G, Kelly M
    NHS funding for a secure future: naming the elephant in the room.
    BMJ. 2024;385:q1036.
    PubMed        
  6. NAKWEYA G
    Moderna’s decision to shelve vaccine plant in Kenya should encourage global south’s self-reliance, says global health adviser.
    BMJ. 2024;385:q1051.
    PubMed        
  7. MAFI A
    Doctors in training should be at the top of the workforce priority list.
    BMJ. 2024;385:q1045.
    PubMed        
  8. WATERS A
    LMC removes GP from committee amid row over attendance at meetings.
    BMJ. 2024;385:q1021.
    PubMed        
  9. LOOI MK
    Why WHO changed the definition of “airborne transmission” in the wake of the pandemic.
    BMJ. 2024;385:q985.
    PubMed        
  10. LYNN E
    April top picks: Hope springs eternal.
    BMJ. 2024;385:q1037.
    PubMed        


    Clin Infect Dis
  11. ANDREWS JS, Boonyaratanakornkit JB, Krusinska E, Allen S, et al
    Assessment of the Impact of RNase in Patients With Severe Fatigue Related to Post-Acute Sequelae of SARS-CoV-2 Infection (PASC): A Randomized Phase 2 Trial of RSLV-132.
    Clin Infect Dis. 2024 May 10:ciae205. doi: 10.1093.
    PubMed         Abstract available


    Int J Infect Dis
  12. XIANG Y, Feng Y, Qiu J, Zhang R, et al
    Association of COVID-19 vaccination with risks of hospitalization due to cardiovascular and other diseases: a study using data from the UK Biobank.
    Int J Infect Dis. 2024 May 1:107080. doi: 10.1016/j.ijid.2024.107080.
    PubMed         Abstract available
  13. SCOTT AJ, Limbada M, Perumal T, Jaumdally S, et al
    Integrating molecular and radiological screening tools during community-based active case-finding for tuberculosis and COVID-19 in southern Africa.
    Int J Infect Dis. 2024 May 1:107081. doi: 10.1016/j.ijid.2024.107081.
    PubMed         Abstract available
  14. VAN VOORDEN J, de Groot CJM, Ris-Stalpers C, Afink GB, et al
    Corrigendum to “COVID-19 mRNA vaccination during pregnancy does not harm syncytiotrophoblast development” [International Journal of Infectious Diseases, 140C (2024) pages 95-98].
    Int J Infect Dis. 2024;144:107068.
    PubMed        
  15. LIN DY, Xu Y, Gu Y, Sunny SK, et al
    Impact of Booster Vaccination Interval on SARS-CoV-2 Infection, Hospitalization, and Death.
    Int J Infect Dis. 2024 May 3:107084. doi: 10.1016/j.ijid.2024.107084.
    PubMed         Abstract available


    Intensive Care Med
  16. MONTOMOLI J, Vergano M, Semeraro F, Bignami EG, et al
    From the pandemic to a war: a call for solidarity with all healthcare workers.
    Intensive Care Med. 2024;50:776-777.
    PubMed        
  17. DE CORTE T, Kohler K, Cecconi M, De Waele JJ, et al
    Characteristics of co-infection and secondary infection amongst critically ill COVID-19 patients in the first two waves of the pandemic.
    Intensive Care Med. 2024 May 6. doi: 10.1007/s00134-024-07444.
    PubMed        


    Invest Radiol
  18. ECKSTEIN J, Skeries V, Pohler G, Babazade N, et al
    Multiparametric Cardiovascular MRI Assessment of Post-COVID Syndrome in Children in Comparison to Matched Healthy Individuals.
    Invest Radiol. 2024;59:472-478.
    PubMed         Abstract available


    J Infect
  19. KIRSEBOM FCM, Stowe J, Lopez Bernal J, Allen A, et al
    Effectiveness of Autumn 2023 COVID-19 vaccination and residual protection of prior doses against hospitalisation in England, estimated using a test-negative case-control study.
    J Infect. 2024 May 6:106177. doi: 10.1016/j.jinf.2024.106177.
    PubMed         Abstract available
  20. HALVORSEN B, Viermyr HK, Ueland T, Sagen EL, et al
    IL-22 is increased in hospitalized patients with COVID-19 and associates with cardiac involvement.
    J Infect. 2024 May 6:106176. doi: 10.1016/j.jinf.2024.106176.
    PubMed        


    J Med Virol
  21. FENG Y, Zhao X, Chen Z, Wu Y, et al
    Prevalence and diversity of imported severe acute respiratory syndrome coronavirus 2 variants in China, 2021-2022.
    J Med Virol. 2024;96:e29664.
    PubMed         Abstract available
  22. ISHII T, Nawa N, Hosokawa S, Morio T, et al
    Exploring viral infections’ role in Kawasaki disease onset: A study during the COVID-19 pandemic.
    J Med Virol. 2024;96:e29660.
    PubMed         Abstract available
  23. ASHOKKUMAR S, Lim JS, Kaushik NK, Han I, et al
    Human coronavirus 229E inactivation on porous and nonporous materials using dielectric barrier discharge (DBD) plasma.
    J Med Virol. 2024;96:e29655.
    PubMed         Abstract available
  24. WU JY, Chen CC, Liu MY, Hsu WH, et al
    Clinical effectiveness of nirmatrelvir plus ritonavir on the short- and long-term outcome in high-risk children with COVID-19.
    J Med Virol. 2024;96:e29662.
    PubMed         Abstract available
  25. CHENG P, Zhai K, Han W, Zeng J, et al
    Characterizing the antigenic evolution of pandemic influenza A (H1N1) pdm09 from 2009 to 2023.
    J Med Virol. 2024;96:e29657.
    PubMed         Abstract available
  26. CHEN SY, Hsieh TYJ, Hung YM, Oh JW, et al
    Prior COVID-19 vaccination and reduced risk of cerebrovascular diseases among COVID-19 survivors.
    J Med Virol. 2024;96:e29648.
    PubMed         Abstract available
  27. RZYMSKI P, Zarebska-Michaluk D, Parczewski M, Genowska A, et al
    The burden of infectious diseases throughout and after the COVID-19 pandemic (2020-2023) and Russo-Ukrainian war migration.
    J Med Virol. 2024;96:e29651.
    PubMed         Abstract available
  28. GRUBER CEM, Tucci FG, Giombini E, Mazzotta V, et al
    Molnupiravir increases SARS-CoV-2 genome diversity and complexity: A case-control cohort study.
    J Med Virol. 2024;96:e29642.
    PubMed         Abstract available


    J Virol
  29. ADAIR A, Tan LL, Feng J, Girkin J, et al
    Human coronavirus OC43 nanobody neutralizes virus and protects mice from infection.
    J Virol. 2024 May 6:e0053124. doi: 10.1128/jvi.00531.
    PubMed         Abstract available
  30. YU M, Li J, Gao W, Li Z, et al
    Multiple E3 ligases act as antiviral factors against SARS-CoV-2 via inducing the ubiquitination and degradation of ORF9b.
    J Virol. 2024 May 6:e0162423. doi: 10.1128/jvi.01624.
    PubMed         Abstract available


    JAMA
  31. HARRIS E
    National Academies Report: COVID-19 Vaccines Don’t Cause Many Potential Harms.
    JAMA. 2024 May 10. doi: 10.1001/jama.2024.7724.
    PubMed        
  32. ANDERER S
    Could “Empathetic Refutation” Help Clinicians Sway Vaccine Skeptics?
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4493.
    PubMed        
  33. AGRAWAL S, Ross JS, Ramachandran R
    Implications for Public Health Regulation if Chevron Deference Is Overturned.
    JAMA. 2024;331:1443-1444.
    PubMed        
  34. HARRIS E
    Trials Will Evaluate Treatments for Long COVID Nervous System Problems.
    JAMA. 2024;331:1439-1440.
    PubMed        


    Lancet
  35. KIVIMAKI M, Batty GD
    Work as a health risk.
    Lancet. 2024;403:1747-1748.
    PubMed        


    Lancet Infect Dis
  36. WANG H, Wei Y, Hung CT, Lin G, et al
    Association of nirmatrelvir-ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study.
    Lancet Infect Dis. 2024 May 3:S1473-3099(24)00217.
    PubMed         Abstract available
  37. ARES-GOMEZ S, Mallah N, Santiago-Perez MI, Pardo-Seco J, et al
    Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study.
    Lancet Infect Dis. 2024 Apr 30:S1473-3099(24)00215.
    PubMed         Abstract available
  38. SORIANO V, Moreno-Torres V
    Oral antivirals for acute symptoms and post-acute sequelae in SARS-CoV-2 infection.
    Lancet Infect Dis. 2024 May 3:S1473-3099(24)00258.
    PubMed        


    Nature
  39. DESAUTELS TA, Arrildt KT, Zemla AT, Lau EY, et al
    Computationally restoring the potency of a clinical antibody against Omicron.
    Nature. 2024 May 8. doi: 10.1038/s41586-024-07385.
    PubMed         Abstract available


    Science
  40. THORP HH
    Mr. Thorp goes to Washington.
    Science. 2024;384:601.
    PubMed         Abstract available
  41. COHEN J
    Virus gone wild.
    Science. 2024;384:615-617.
    PubMed         Abstract available


    Zhonghua Jie He He Hu Xi Za Zhi
  42. YANG LL, Huang LT, Ren SY, Ouyang RY, et al
    [COVID-19 in patients with Good syndrome: report of 4 cases and literature review].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:430-436.
    PubMed         Abstract available
  43. LIU MH, Sun YX, Li ZL, Zhang LJ, et al
    [Retrospective analysis of diagnosis and treatment of tuberculosis in designated medical institutions in China from 2017 to 2022].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:437-443.
    PubMed         Abstract available
  44. GU SJ, Wen JL, Wang XY, Zhang LX, et al
    [Progress in the diagnose and treatment of pulmonary arterial thrombosis in situ].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:464-469.
    PubMed         Abstract available

#Influenza and other Respiratory Viruses Research #References (by AMEDEO, May 11 ’24)

  1. LIN X, Chen X, Chen Y, Xu P, et al
    Sleep initiation patterns and sleep quality among toddlers in the southeast of China: initial study results.
    BMC Pediatr. 2024;24:298.
    PubMed         Abstract available


    BMJ

  2. Seven days in medicine: 1-7 May 2024.
    BMJ. 2024;385:q1022.
    PubMed        
  3. MAHASE E
    Workforce and winter under Labour: Wes Streeting on his plan for the NHS and ending the strikes.
    BMJ. 2024;385:q992.
    PubMed        
  4. WONG G, Kelly M
    NHS funding for a secure future: naming the elephant in the room.
    BMJ. 2024;385:q1036.
    PubMed        
  5. NAKWEYA G
    Moderna’s decision to shelve vaccine plant in Kenya should encourage global south’s self-reliance, says global health adviser.
    BMJ. 2024;385:q1051.
    PubMed        
  6. MAFI A
    Doctors in training should be at the top of the workforce priority list.
    BMJ. 2024;385:q1045.
    PubMed        
  7. WATERS A
    LMC removes GP from committee amid row over attendance at meetings.
    BMJ. 2024;385:q1021.
    PubMed        
  8. LOOI MK
    Why WHO changed the definition of “airborne transmission” in the wake of the pandemic.
    BMJ. 2024;385:q985.
    PubMed        
  9. LYNN E
    April top picks: Hope springs eternal.
    BMJ. 2024;385:q1037.
    PubMed        


    Epidemiol Infect
  10. GUERRERO-SOLER M, Gras-Valenti P, Gomez-Sotero IL, Platas-Abenza G, et al
    Impact of COVID-19 on the degree of compliance with hand hygiene: a repeated cross-sectional study.
    Epidemiol Infect. 2024;152:e69.
    PubMed         Abstract available


    J Clin Microbiol
  11. SMY L, Ledeboer NA, Wood MG
    At-home testing for respiratory viruses: a minireview of the current landscape.
    J Clin Microbiol. 2024;62:e0031223.
    PubMed         Abstract available


    J Epidemiol Community Health
  12. YEUNG A, Wilkinson M, Bishop J, Taylor B, et al
    SARS-CoV-2 vaccine uptake and risks of severe COVID-19 disease among people prescribed opioid agonist therapy in Scotland.
    J Epidemiol Community Health. 2024;78:380-387.
    PubMed         Abstract available


    J Gen Virol
  13. KARA Y, Kizil MC, Iseri Nepesov M, Kacmaz E, et al
    Assessing the change in the epidemiology of seasonal respiratory viruses with the onset of the COVID-19 pandemic.
    J Gen Virol. 2024;105.
    PubMed         Abstract available


    J Immunol
  14. BOUCHER J, Gilbert C, Bose S, Tessier PA, et al
    S100A9: The Unusual Suspect Connecting Viral Infection and Inflammation.
    J Immunol. 2024;212:1523-1529.
    PubMed         Abstract available
  15. SAITO S, Bozorgmehr N, Sligl W, Osman M, et al
    The Role of Coinhibitory Receptors in B Cell Dysregulation in SARS-CoV-2-Infected Individuals with Severe Disease.
    J Immunol. 2024;212:1540-1552.
    PubMed         Abstract available


    J Infect Dis
  16. HOY G, Stadlbauer D, Balmaseda A, Kuan G, et al
    Humoral correlates of protection against influenza A H3N2 virus infection.
    J Infect Dis. 2024 May 9:jiae258. doi: 10.1093.
    PubMed         Abstract available


    JAMA
  17. AGRAWAL S, Ross JS, Ramachandran R
    Implications for Public Health Regulation if Chevron Deference Is Overturned.
    JAMA. 2024;331:1443-1444.
    PubMed        
  18. HARRIS E
    Trials Will Evaluate Treatments for Long COVID Nervous System Problems.
    JAMA. 2024;331:1439-1440.
    PubMed        
  19. HARRIS E
    Safety Concerns Put a Stop to Maternal RSV Vaccine Study.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5155.
    PubMed        
  20. HARRIS E
    COVID-19 Vaccination Linked With Lower Risk of Cardiac Problems.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5152.
    PubMed        
  21. ANDERER S
    Could “Empathetic Refutation” Help Clinicians Sway Vaccine Skeptics?
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4493.
    PubMed        


    Lancet
  22. KIVIMAKI M, Batty GD
    Work as a health risk.
    Lancet. 2024;403:1747-1748.
    PubMed        
  23. ZUMLA A, Peiris M, Memish ZA, Perlman S, et al
    Anticipating a MERS-like coronavirus as a potential pandemic threat.
    Lancet. 2024 Apr 8:S0140-6736(24)00641-X. doi: 10.1016/S0140-6736(24)00641.
    PubMed        


    Pediatrics
  24. MORO PL, Scheffey A, Gallego R, Jones JM, et al
    Incorrect Administration of Adult RSV Vaccines to Young Children.
    Pediatrics. 2024;153:e2024066174.
    PubMed        


    PLoS Comput Biol
  25. BOUMAN JA, Hauser A, Grimm SL, Wohlfender M, et al
    Bayesian workflow for time-varying transmission in stratified compartmental infectious disease transmission models.
    PLoS Comput Biol. 2024;20:e1011575.
    PubMed         Abstract available


    PLoS One
  26. SELVAVINAYAGAM TS, Viswanathan V, Ramalingam A, Kangusamy B, et al
    Prevalence of Noncommunicable Disease (NCDs) risk factors in Tamil Nadu: Tamil Nadu STEPS Survey (TN STEPS), 2020.
    PLoS One. 2024;19:e0298340.
    PubMed         Abstract available
  27. VOLTMER K, von Salisch M
    Longitudinal prediction of primary school children’s COVID-related future anxiety in the second year of the pandemic in Germany.
    PLoS One. 2024;19:e0302065.
    PubMed         Abstract available
  28. IQBAL NT, Ahmed K, Sattar T, Aziz F, et al
    BCG activation of trained immunity is associated with induction of cross reactive COVID-19 antibodies in a BCG vaccinated population.
    PLoS One. 2024;19:e0302722.
    PubMed         Abstract available
  29. VAMEGHI M, Saatchi M, Bahrami G, Soleimani F, et al
    How did we protect children against COVID-19 in Iran? Prevalence of COVID-19 and vaccination in the socio-economic context of COVID-19 epidemic.
    PLoS One. 2024;19:e0303043.
    PubMed         Abstract available
  30. MALKOWSKI OS, Townsend NP, Kelson MJ, Foster CEM, et al
    Socio-economic inequalities in the breadth of internet use before and during the COVID-19 pandemic among older adults in England.
    PLoS One. 2024;19:e0303061.
    PubMed         Abstract available
  31. AL MAQBALI M, Alsayed A, Hughes C, Hacker E, et al
    Stress, anxiety, depression and sleep disturbance among healthcare professional during the COVID-19 pandemic: An umbrella review of 72 meta-analyses.
    PLoS One. 2024;19:e0302597.
    PubMed         Abstract available
  32. OMALE UI, Ikegwuonu CO, Nkwo GE, Nwali UIA, et al
    COVID-19 and COVID-19 vaccination experiences and perceptions among health workers during the pandemic in Ebonyi state, Nigeria: An analytical cross-sectional study.
    PLoS One. 2024;19:e0303172.
    PubMed         Abstract available
  33. AGGARWAL S, Singh L, Alam U, Sharma S, et al
    COVID-19 vaccine hesitancy among adults in India: A primary study based on health behavior theories and 5C psychological antecedents model.
    PLoS One. 2024;19:e0294480.
    PubMed         Abstract available
  34. LIU X, Xie CP
    Person-organization fit and job burnout of researchers during the COVID-19 pandemic: Heterogeneity in eleven countries.
    PLoS One. 2024;19:e0302296.
    PubMed         Abstract available
  35. NAPOLITANO JM, Srikanth S, Noorai RE, Wilson S, et al
    SARS-CoV-2 variant introduction following spring break travel and transmission mitigation strategies.
    PLoS One. 2024;19:e0301225.
    PubMed         Abstract available
  36. MEYER C, Crayton E, Wright A, Spyer M, et al
    Factors influencing uptake of protective behaviours by healthcare workers in England during the COVID-19 pandemic: A theory-based mixed-methods study.
    PLoS One. 2024;19:e0299823.
    PubMed         Abstract available
  37. GALIERO R, Loffredo G, Simeon V, Caturano A, et al
    Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy.
    PLoS One. 2024;19:e0296495.
    PubMed         Abstract available
  38. PASAT Z, Sinn CJ, Rahman B, Gayowsky A, et al
    The relationship between patient experience and real-world digital health access in primary care: A population-based cross-sectional study.
    PLoS One. 2024;19:e0299005.
    PubMed         Abstract available
  39. SCOGLIO AAJ, Nishimi K, Choi KW, Koenen KC, et al
    Prior resilience to trauma & coping during the COVID-19 pandemic.
    PLoS One. 2024;19:e0297169.
    PubMed         Abstract available
  40. GROSS RS, Thaweethai T, Rosenzweig EB, Chan J, et al
    Researching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design.
    PLoS One. 2024;19:e0285635.
    PubMed         Abstract available
  41. ROCA C, Asturizaga A, Villca N, Cabrera R, et al
    Relationship between sociodemographic, clinical, and laboratory characteristics and severity of COVID-19 in pediatric patients.
    PLoS One. 2024;19:e0283037.
    PubMed         Abstract available
  42. FERNANDEZ D, Perez-Alvarez N, Molist G
    COVID-19 patient profiles over four waves in Barcelona metropolitan area: A clustering approach.
    PLoS One. 2024;19:e0302461.
    PubMed         Abstract available
  43. DE WITTE D, Abad AA, Neyens T, Verbeke G, et al
    A joint penalized spline smoothing model for the number of positive and negative COVID-19 tests.
    PLoS One. 2024;19:e0303254.
    PubMed         Abstract available
  44. AALOKKEN TM, Ashraf H, Einvik G, Lerum TV, et al
    CT abnormalities 3 and 12 months after hospitalization for COVID-19 and association with disease severity: A prospective cohort study.
    PLoS One. 2024;19:e0302896.
    PubMed         Abstract available
  45. GNADE CM, Avery CC, Yang Z, Pickett CM, et al
    Social media trends in obstetrics and gynecology residency programs on Instagram and X (Twitter).
    PLoS One. 2024;19:e0296930.
    PubMed         Abstract available
  46. CARDENAS-CALLE M, Patino L, Pernia B, Erazo R, et al
    Detection of thermotolerant coliforms and SARS-CoV-2 RNA in sewage and recreational waters in the Ecuadorian coast: A call for improving water quality regulation.
    PLoS One. 2024;19:e0302000.
    PubMed         Abstract available
  47. KIM S, Lilani A, Redemptus C, Campana K, et al
    A pre-post evaluation study of a social media-based COVID-19 communication campaign to improve attitudes and behaviors toward COVID-19 vaccination in Tanzania.
    PLoS One. 2024;19:e0300206.
    PubMed         Abstract available
  48. WEBB EJD, Conaghan PG, Henderson M, Hulme C, et al
    Long-term health conditions and UK labour market outcomes during the COVID-19 pandemic.
    PLoS One. 2024;19:e0302746.
    PubMed         Abstract available
  49. DU W, Zhao L, Wu R, Huang B, et al
    Predicting drug-Protein interaction with deep learning framework for molecular graphs and sequences: Potential candidates against SAR-CoV-2.
    PLoS One. 2024;19:e0299696.
    PubMed         Abstract available
  50. ELIAS TP, Gebreamlak TW, Gebremeskel TT, Adde BL, et al
    Determinants of post-acute COVID-19 syndrome among hospitalized severe COVID-19 patients: A 2-year follow-up study.
    PLoS One. 2024;19:e0298409.
    PubMed         Abstract available
  51. PALL T, Abroi A, Avi R, Niglas H, et al
    SARS-CoV-2 clade dynamics and their associations with hospitalisations during the first two years of the COVID-19 pandemic.
    PLoS One. 2024;19:e0303176.
    PubMed         Abstract available
  52. RAMOS A, Martins S, Marinho AS, Norton P, et al
    Evaluation of SARS-CoV-2 interferon gamma release assay in BNT162b2 vaccinated healthcare workers.
    PLoS One. 2024;19:e0303244.
    PubMed         Abstract available
  53. TO T, Zhu J, Terebessy E, Borkhoff CM, et al
    Mode of delivery and birth outcomes before and during COVID-19 -A population-based study in Ontario, Canada.
    PLoS One. 2024;19:e0303175.
    PubMed         Abstract available
  54. VINDEIRINHO JM, Oliveira R, Pinho E, Guiomar R, et al
    The potential of tailed amplicons for SARS-CoV-2 detection in Nucleic Acid Lateral Flow Assays.
    PLoS One. 2024;19:e0301234.
    PubMed         Abstract available
  55. MARTELL M, Terry N, Sengupta R, Salazar C, et al
    Open-source data pipeline for street-view images: A case study on community mobility during COVID-19 pandemic.
    PLoS One. 2024;19:e0303180.
    PubMed         Abstract available
  56. BAUTISTA-ARREDONDO LF, Munoz-Rocha TV, Figueroa JL, Tellez-Rojo MM, et al
    A surge in food insecurity during the COVID-19 pandemic in a cohort in Mexico City.
    PLoS One. 2024;19:e0297694.
    PubMed         Abstract available
  57. YASOPA O, Homkham N, Chompook P
    Factors affecting the number of influenza patients before and during COVID-19 pandemic, Thailand.
    PLoS One. 2024;19:e0303382.
    PubMed         Abstract available
  58. FERDOUS MZ, Islam MS, Kundu LR, Islam US, et al
    Patterns of eating behaviors, physical activity, and lifestyle modifications among Bangladeshi adolescents during the COVID-19 pandemic.
    PLoS One. 2024;19:e0302571.
    PubMed         Abstract available
  59. CHEN N, Wang R, Zhu W, Hao X, et al
    Development and characterization of an antibody that recognizes influenza virus N1 neuraminidases.
    PLoS One. 2024;19:e0302865.
    PubMed         Abstract available
  60. KERN M, Glatz T, Mall MA, Seybold J, et al
    Health-related quality of life and impact of socioeconomic status among primary and secondary school students after the third COVID-19 wave in Berlin, Germany.
    PLoS One. 2024;19:e0302995.
    PubMed         Abstract available
  61. NOUR D, Ismail MB, Osman M, Rafei R, et al
    Evaluation of SARS-CoV-2 anti-Spike antibody levels and breakthrough infection risk among vaccinated adults in North Lebanon.
    PLoS One. 2024;19:e0302579.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A
  62. MORALES M, Yang MY, Goddard WA 3rd, Gray HB, et al
    Copper(II) coordination to the intrinsically disordered region of SARS-CoV-2 Nsp1.
    Proc Natl Acad Sci U S A. 2024;121:e2402653121.
    PubMed         Abstract available


    Vaccine
  63. WALLACE M, Rosenblum HG, Moulia DL, Broder KR, et al
    A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States.
    Vaccine. 2023 Jul 30:S0264-410X(23)00868-X. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
  64. EHRLICH KB, Lyle SM, Corallo KL, Lavner JA, et al
    Changes in depressive symptoms and antibody production following influenza vaccination in adolescents and adults.
    Vaccine. 2024 May 2:S0264-410X(24)00505-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  65. BENEDICT KPOZEHOUEN E, Macintyre CR, Tan TC
    Determinants of uptake of influenza, zoster and pneumococcal vaccines in patients with cardiovascular diseases.
    Vaccine. 2024 May 3:S0264-410X(24)00445-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  66. MAUREL M, Mazagatos C, Goerlitz L, Oroszi B, et al
    Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022-23 VEBIS multicentre study in Europe.
    Vaccine. 2024 May 3:S0264-410X(24)00497-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  67. SHI XC, Gruber JF, Ondari M, Lloyd PC, et al
    Assessment of potential adverse events following the 2022-2023 seasonal influenza vaccines among U.S. adults aged 65 years and older.
    Vaccine. 2024 May 3:S0264-410X(24)00478-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  68. KIM J, Chang J
    Cross-protective efficacy and safety of an adenovirus-based universal influenza vaccine expressing nucleoprotein, hemagglutinin, and the ectodomain of matrix protein 2.
    Vaccine. 2024 May 6:S0264-410X(24)00481-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  69. KIM DH, Lee SH, Kim J, Lee J, et al
    Efficacy of live and inactivated recombinant Newcastle disease virus vaccines expressing clade 2.3.4.4b H5 hemagglutinin against H5N1 highly pathogenic avian influenza in SPF chickens, Broilers, and domestic ducks.
    Vaccine. 2024 May 8:S0264-410X(24)00527-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


    Virus Res
  70. WU CC, Tam EH, Shih YY, Lin YR, et al
    Exploration of influenza A virus PA protein-associated cellular proteins discloses its impact on mitochondrial function.
    Virus Res. 2024 May 6:199387. doi: 10.1016/j.virusres.2024.199387.
    PubMed         Abstract available

#Coronavirus Disease Research #References (by Amedeo.com, May 4 ’24)

  1. GRADY E, Pattison DA, Redman S, Satoh Y, et al
    The Global Reading Room: Performing a Ventilation-Perfusion Study in a Patient With Recent COVID-19.
    AJR Am J Roentgenol. 2024 May 1. doi: 10.2214/AJR.24.31348.
    PubMed        


    Am J Obstet Gynecol
  2. MAGNUS MC, Rasmussen TD, Ortqvist AK, Oakley LL, et al
    Covid-19 vaccination during pregnancy is not associated with an increased risk of severe post-partum hemorrhage.
    Am J Obstet Gynecol. 2024 Apr 30:S0002-9378(24)00554.
    PubMed        


    Am J Respir Crit Care Med
  3. AZOULAY E, Pochard F, Argaud L, Kentish-Barnes N, et al
    Reply to Zijlstra: Resilience and Stress Are Heterogenic Too, We Should Act Accordingly.
    Am J Respir Crit Care Med. 2024 May 3. doi: 10.1164/rccm.202404-0790.
    PubMed        


    Antiviral Res
  4. LIU X, Wang Y, Sun L, Xiao G, et al
    Screening and optimization of shark nanobodies against SARS-CoV-2 Spike RBD.
    Antiviral Res. 2024 Apr 29:105898. doi: 10.1016/j.antiviral.2024.105898.
    PubMed         Abstract available
  5. ARDUINO I, Francese R, Civra A, Feyles E, et al
    Polyoxometalate exerts broad-spectrum activity against human respiratory viruses hampering viral entry.
    Antiviral Res. 2024;226:105897.
    PubMed         Abstract available
  6. AMERATUNGA R, Jordan A, Lehnert K, Leung E, et al
    SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?
    Antiviral Res. 2024 Apr 25:105894. doi: 10.1016/j.antiviral.2024.105894.
    PubMed         Abstract available


    BMJ
  7. SILLETT JM
    Perhaps politicians and health leaders could ?
    BMJ. 2024;385:q976.
    PubMed        
  8. MATHEW R
    Rammya Mathew: We can’t overlook the backdrop as Britain becomes “a sicker nation”.
    BMJ. 2024;385:q956.
    PubMed        
  9. WISE J
    MP resigns from Tory party over NHS “stretched close to breaking point”.
    BMJ. 2024;385:q983.
    PubMed        
  10. MIDDLETON J, Saunders P
    What will it take for a new sanitary revolution in the UK?
    BMJ. 2024;385:q974.
    PubMed        
  11. MORGAN SG
    When will Canada have national pharmacare?
    BMJ. 2024;385:q887.
    PubMed        
  12. TANNE JH
    US pregnant workers get new legal protections, but not paid time off.
    BMJ. 2024;385:q926.
    PubMed        
  13. MAHASE E
    Doctors will shape Labour’s 10 year plan to fix NHS crisis, says shadow health secretary.
    BMJ. 2024;385:q980.
    PubMed        
  14. MCCARTNEY M, Liu PJ, Fearfull A, Macdonald H, et al
    Early diagnosis is not always an unmitigated good, we need to make it useful for patients and clinicians.
    BMJ. 2024;385:q973.
    PubMed        

  15. Clinical effectiveness of an online supervised group physical and mental health rehabilitation programme for adults with post-covid-19 condition (REGAIN study): multicentre randomised controlled trial.
    BMJ. 2024;385:q988.
    PubMed        
  16. LANG K
    What do we know about covid-19’s effects on the gut?
    BMJ. 2024;385:q842.
    PubMed        

  17. Seven days in medicine: 24-30 April 2024.
    BMJ. 2024;385:q969.
    PubMed        


    Br J Anaesth
  18. BOWDLE A, Brosseau LM, Tellier R, MacIntyre CR, et al
    Reducing airborne transmissible diseases in perioperative environments.
    Br J Anaesth. 2024 Apr 26:S0007-0912(24)00181-8. doi: 10.1016/j.bja.2024.
    PubMed         Abstract available


    Clin Infect Dis
  19. JORGENSEN SCJ, Brown K, Clarke AE, Schwartz KL, et al
    The Effect of COVID-19 Vaccination on Outpatient Antibiotic Prescribing in Older Adults: A Self-Controlled Risk-Interval Study.
    Clin Infect Dis. 2024 May 3:ciae182. doi: 10.1093.
    PubMed         Abstract available
  20. BRAMANTE CT, Beckman KB, Mehta T, Karger AB, et al
    Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019.
    Clin Infect Dis. 2024 May 1:ciae159. doi: 10.1093.
    PubMed         Abstract available
  21. SIEDNER MJ, Sax PE
    Repurposing Revisited: Exploring the Role of Metformin for Treatment of Coronavirus Disease 2019.
    Clin Infect Dis. 2024 May 1:ciae154. doi: 10.1093.
    PubMed        

  22. Correction to: Impact of Seasonal Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responses in Solid Organ Transplant Recipients.
    Clin Infect Dis. 2024 Apr 30:ciae164. doi: 10.1093.
    PubMed        

  23. Correction to: Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology.
    Clin Infect Dis. 2024 Apr 30:ciae166. doi: 10.1093.
    PubMed        


    Int J Infect Dis
  24. XIE H, Zhang J, Bai S, Lv M, et al
    The contributions of vaccination and natural infection to the production of neutralizing antibodies against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) prototype strain and variants.
    Int J Infect Dis. 2024 Apr 24:107060. doi: 10.1016/j.ijid.2024.107060.
    PubMed         Abstract available
  25. MARTINEZ-FIERRO ML, Perez-Favila A, Alfaro SMZ, Oropeza-de Lara SA, et al
    Gene variants rs5182, rs2074192, and rs4343 in the Renin-Angiotensin-Aldosterone system are associated with symptom severity, higher odds of hospitalization, and death in COVID-19.
    Int J Infect Dis. 2024 Apr 30:107067. doi: 10.1016/j.ijid.2024.107067.
    PubMed         Abstract available
  26. YAN X, Zhao X, Du Y, Wang H, et al
    Dynamics of anti-SARS-CoV-2 IgG antibody responses following breakthrough infection and the predicted protective efficacy: a longitudinal community-based population study in China.
    Int J Infect Dis. 2024 Apr 30:107075. doi: 10.1016/j.ijid.2024.107075.
    PubMed         Abstract available
  27. MURRAY HC, Muleme M, Cooper D, McNamara BJ, et al
    Prevalence, risk factors and outcomes of secondary infections among hospitalised patients with COVID-19 or post-COVID-19 conditions in Victoria, 2020-2023.
    Int J Infect Dis. 2024 Apr 30:107078. doi: 10.1016/j.ijid.2024.107078.
    PubMed         Abstract available


    J Med Virol
  28. ZHAO XJ, Liu XL, Liang YM, Zhang S, et al
    Epidemiological characteristics and antibody kinetics of elderly population with booster vaccination following both Omicron BA.5 and XBB waves in China.
    J Med Virol. 2024;96:e29640.
    PubMed         Abstract available
  29. TANG Z, Mao Y, Ruan P, Li J, et al
    Drugs targeting CMPK2 inhibit pyroptosis to alleviate severe pneumonia caused by multiple respiratory viruses.
    J Med Virol. 2024;96:e29643.
    PubMed         Abstract available
  30. MATUSALI G, Mazzotta V, Meschi S, Colavita F, et al
    JN.1 neutralizing antibody titers after XBB.1.5 monovalent vaccine boost in healthcare workers and people with HIV.
    J Med Virol. 2024;96:e29631.
    PubMed        
  31. GAO R, Feng C, Sheng Z, Li F, et al
    Research progress in Fc-effector functions against SARS-CoV-2.
    J Med Virol. 2024;96:e29638.
    PubMed         Abstract available
  32. WANG F, Gao Y, Wagner AL, Lu Y, et al
    A systematic review and meta-analysis of herpes zoster occurrence/recurrence after COVID-19 infection and vaccination.
    J Med Virol. 2024;96:e29629.
    PubMed         Abstract available
  33. THOMAS S, Smatti MK, Alsulaiti H, Zedan HT, et al
    Antibody-dependent enhancement (ADE) of SARS-CoV-2 in patients exposed to MERS-CoV and SARS-CoV-2 antigens.
    J Med Virol. 2024;96:e29628.
    PubMed         Abstract available


    Lancet
  34. GREEN A
    Tobias Welte.
    Lancet. 2024;403:1626.
    PubMed        
  35. ADEPOJU P
    Moderna stalls on African vaccine manufacturing plans.
    Lancet. 2024;403:1617.
    PubMed        
  36. MARCHALIK D, Rehm D
    On not cutting corners.
    Lancet. 2024;403:1623.
    PubMed        


    Lancet Infect Dis
  37. KEDDY KH, Tadesse BT
    Inaccessible: health, wealth, governance, and equity in low-income and middle-income countries.
    Lancet Infect Dis. 2024;24:444-445.
    PubMed        
  38. KOCHER K, Moosmann C, Drost F, Schulein C, et al
    Adaptive immune responses are larger and functionally preserved in a hypervaccinated individual.
    Lancet Infect Dis. 2024;24:e272-e274.
    PubMed        
  39. LIN DY, Huang S, Milinovich A, Duggal A, et al
    Effectiveness of XBB.1.5 vaccines and antiviral drugs against severe outcomes of omicron infection in the USA.
    Lancet Infect Dis. 2024;24:e278-e280.
    PubMed        
  40. DE AMBROGI M
    A summer cold.
    Lancet Infect Dis. 2024;24:461.
    PubMed        
  41. KAZI F, Mushtaq A
    Nuria Izquierdo-Useros-fighting the good fight.
    Lancet Infect Dis. 2024;24:458.
    PubMed        
  42. MOODY J
    On the frontline during the COVID-19 pandemic.
    Lancet Infect Dis. 2024;24:464.
    PubMed        
  43. VISSER LG
    Identifying efficacious SARS-CoV-2 antivirals in a changing immune landscape.
    Lancet Infect Dis. 2024 Apr 24:S1473-3099(24)00254.
    PubMed        
  44. WONGNAK P, Schilling WHK, Jittamala P, Boyd S, et al
    Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV).
    Lancet Infect Dis. 2024 Apr 24:S1473-3099(24)00183.
    PubMed         Abstract available
  45. VENKATESAN P
    Tobias Welte.
    Lancet Infect Dis. 2024;24:457.
    PubMed        


    MMWR Morb Mortal Wkly Rep
  46. XIE AG, Yomogida K, Berry I, Briggs NL, et al
    Notes from the Field: Increase in Nontoxigenic Corynebacterium diphtheriae – Washington, 2018-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:405-407.
    PubMed        


    Nature
  47. CALLAWAY E
    Scientists tried to give people COVID – and failed.
    Nature. 2024 May 1. doi: 10.1038/d41586-024-01284.
    PubMed        
  48. MALLAPATY S
    Chinese virologist who was first to share COVID-19 genome sleeps on street after lab shuts.
    Nature. 2024 May 1. doi: 10.1038/d41586-024-01293.
    PubMed        
  49. LENHARO M, Wolf L
    Controversial virus-hunting scientist skewered at US COVID-origins hearing.
    Nature. 2024 May 1. doi: 10.1038/d41586-024-01305.
    PubMed        


    Radiology
  50. SUTHAR PP, Hughes K, Mafraji M, Akyuz M, et al
    Case 324: CHANTER Syndrome.
    Radiology. 2024;311:e222748.
    PubMed         Abstract available


    Science
  51. CICERO A, Phelan A
    A pandemic agreement is within reach.
    Science. 2024;384:489.
    PubMed         Abstract available
  52. LYNTERIS C
    Pandemics and their accelerantsThe Human Disease: How We Create Pandemics, from Our Bodies to Our Beliefs Sabrina Sholts MIT Press, 2024. 352 pp.
    Science. 2024;384:517.
    PubMed         Abstract available

#Influenza and #COVID19 Research #References (by Amedeo.com, May 4 ’24)

  1. LU A, Chen CC, Lin C, Wu TJ, et al
    Artificial Intelligence Electrocardiography Detecting Thyrotoxic Periodic Paralysis Following a SARS-CoV-2 Infection.
    Am J Med. 2024 Jan 25:S0002-9343(24)00054-8. doi: 10.1016/j.amjmed.2024.
    PubMed        


    Antimicrob Agents Chemother
  2. CLEGG LE, Stepanov O, Schmidt H, Tang W, et al
    Accelerating therapeutics development during a pandemic: population pharmacokinetics of the long-acting antibody combination AZD7442 (tixagevimab/cilgavimab) in the prophylaxis and treatment of COVID-19.
    Antimicrob Agents Chemother. 2024;68:e0158723.
    PubMed         Abstract available


    Biochem Biophys Res Commun
  3. KAWAI A, Hirata H, Tokunoh N, Ono C, et al
    Adjuvant-free parenterally injectable vaccine platform that harnesses previously induced IgG as an antigen delivery carrier.
    Biochem Biophys Res Commun. 2024;711:149919.
    PubMed         Abstract available
  4. BAI G, Zeng X, Zhang L, Wang Y, et al
    Computational investigation of the inhibitory interaction of IRF3 and SARS-CoV-2 accessory protein ORF3b.
    Biochem Biophys Res Commun. 2024;712-713:149945.
    PubMed         Abstract available
  5. KOMU JG, Jamsransuren D, Matsuda S, Ogawa H, et al
    Collection and transportation of SARS-CoV-2 and influenza A virus diagnostic samples: Optimizing the usage of guanidine-based chaotropic salts for enhanced biosafety and viral genome preservation.
    Biochem Biophys Res Commun. 2024;715:149994.
    PubMed         Abstract available


    BMC Pediatr
  6. OGILVIE RP, Layton JB, Lloyd PC, Jiao Y, et al
    Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5-17 years in the United States: a cohort study.
    BMC Pediatr. 2024;24:276.
    PubMed         Abstract available


    BMJ

  7. Seven days in medicine: 24-30 April 2024.
    BMJ. 2024;385:q969.
    PubMed        
  8. LANG K
    What do we know about covid-19’s effects on the gut?
    BMJ. 2024;385:q842.
    PubMed        
  9. MCCARTNEY M, Liu PJ, Fearfull A, Macdonald H, et al
    Early diagnosis is not always an unmitigated good, we need to make it useful for patients and clinicians.
    BMJ. 2024;385:q973.
    PubMed        
  10. TANNE JH
    US pregnant workers get new legal protections, but not paid time off.
    BMJ. 2024;385:q926.
    PubMed        
  11. MAHASE E
    Doctors will shape Labour’s 10 year plan to fix NHS crisis, says shadow health secretary.
    BMJ. 2024;385:q980.
    PubMed        
  12. SILLETT JM
    Perhaps politicians and health leaders could ?
    BMJ. 2024;385:q976.
    PubMed        
  13. MATHEW R
    Rammya Mathew: We can’t overlook the backdrop as Britain becomes “a sicker nation”.
    BMJ. 2024;385:q956.
    PubMed        
  14. WISE J
    MP resigns from Tory party over NHS “stretched close to breaking point”.
    BMJ. 2024;385:q983.
    PubMed        
  15. MIDDLETON J, Saunders P
    What will it take for a new sanitary revolution in the UK?
    BMJ. 2024;385:q974.
    PubMed        
  16. MORGAN SG
    When will Canada have national pharmacare?
    BMJ. 2024;385:q887.
    PubMed        


    Epidemiol Infect
  17. CHAMBERS T, Anglemyer A, Chen A, Atkinson J, et al
    Population and contact tracer uptake of New Zealand’s QR-code-based digital contact tracing app for COVID-19.
    Epidemiol Infect. 2024;152:e66.
    PubMed         Abstract available


    J Gen Virol
  18. AHRENS AK, Jonsson SR, Svansson V, Brugger B, et al
    Iceland: an underestimated hub for the spread of high-pathogenicity avian influenza viruses in the North Atlantic.
    J Gen Virol. 2024;105.
    PubMed         Abstract available


    J Infect
  19. CANE J, Sanderson N, Barnett S, Vaughan A, et al
    Nanopore sequencing of influenza A and B in Oxfordshire and the United Kingdom, 2022-23.
    J Infect. 2024 Apr 29:106164. doi: 10.1016/j.jinf.2024.106164.
    PubMed         Abstract available
  20. PINANA M, Gonzalez-Sanchez A, Andres C, Vila J, et al
    Genomic evolution of human respiratory syncytial virus during a decade (2013-2023): bridging the path to monoclonal antibody surveillance.
    J Infect. 2024 Apr 6:106153. doi: 10.1016/j.jinf.2024.106153.
    PubMed         Abstract available
  21. CAINI S, Casalegno JS, Rodrigues AP, Lee V, et al
    Change in Age profile of Respiratory Syncytial Virus disease over the course of annual epidemics: a multi-national study.
    J Infect. 2024;88:106154.
    PubMed         Abstract available
  22. COLSON P, Chaudet H, Delerce J, Pontarotti P, et al
    Role of SARS-CoV-2 mutations in the evolution of the COVID-19 pandemic.
    J Infect. 2024 Apr 1:106150. doi: 10.1016/j.jinf.2024.106150.
    PubMed         Abstract available
  23. GAYLIS NB, Yang OO
    Understanding immune dysregulation in post-acute sequelae of COVID-19 (PASC) – The hunt for effective treatments.
    J Infect. 2024 Mar 24:106146. doi: 10.1016/j.jinf.2024.106146.
    PubMed        
  24. SALMAN M, Rana MS, Usman M, Tahir M, et al
    Re-emergence of Diphtheria after COVID-19 Pandemic in Pakistan: time to consider booster vaccination strategies.
    J Infect. 2024 Mar 19:106141. doi: 10.1016/j.jinf.2024.106141.
    PubMed        
  25. POWELL AA, Dowell AC, Moss P, Ladhani SN, et al
    Current state of COVID-19 in children: 4 years on.
    J Infect. 2024 Mar 1:106134. doi: 10.1016/j.jinf.2024.106134.
    PubMed         Abstract available


    J Infect Dis
  26. BI Q, Dickerman BA, Nguyen HQ, Martin ET, et al
    Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection.
    J Infect Dis. 2024 Apr 30:jiae220. doi: 10.1093.
    PubMed         Abstract available


    J Virol Methods
  27. KRUNKOSKY M, Krunkosky TM, Meliopoulos V, Kyriakis CS, et al
    Establishment of Swine Primary Nasal, Tracheal, and Bronchial Epithelial Cell Culture Models for the Study of Influenza Virus Infection.
    J Virol Methods. 2024 Apr 26:114943. doi: 10.1016/j.jviromet.2024.114943.
    PubMed         Abstract available
  28. AN SH, Kim NY, Heo GB, Kang YM, et al
    Development and evaluation of a multiplex real-time RT-PCR assay for simultaneous detection of H5, H7, and H9 subtype avian influenza viruses.
    J Virol Methods. 2024;327:114942.
    PubMed         Abstract available


    Lancet
  29. MARCHALIK D, Rehm D
    On not cutting corners.
    Lancet. 2024;403:1623.
    PubMed        
  30. GREEN A
    Tobias Welte.
    Lancet. 2024;403:1626.
    PubMed        


    N Engl J Med
  31. UYEKI TM, Milton S, Abdul Hamid C, Reinoso Webb C, et al
    Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Dairy Farm Worker.
    N Engl J Med. 2024 May 3. doi: 10.1056/NEJMc2405371.
    PubMed        


    Pediatrics
  32. DEWALD F, Steger G, Fish I, Torre-Lage I, et al
    SARS-CoV-2 Test-to-Stay in Daycare.
    Pediatrics. 2024;153:e2023064668.
    PubMed         Abstract available
  33. SENTER JP, Aisenberg LK, Dudley JW, Luan X, et al
    COVID-19 and Asthma Onset in Children.
    Pediatrics. 2024 Apr 12:e2023064615. doi: 10.1542/peds.2023-064615.
    PubMed         Abstract available
  34. SAPER JK, Heffernan M, Simon NE, Davis MM, et al
    RSV Vaccination Intention Among People Who Are or Plan to Become Pregnant.
    Pediatrics. 2024 Apr 25:e2023065140. doi: 10.1542/peds.2023-065140.
    PubMed         Abstract available


    PLoS Med
  35. JUNG SM, Loo SL, Howerton E, Contamin L, et al
    Potential impact of annual vaccination with reformulated COVID-19 vaccines: Lessons from the US COVID-19 scenario modeling hub.
    PLoS Med. 2024;21:e1004387.
    PubMed         Abstract available


    PLoS One
  36. CHEN C, Martins M, Nooruzzaman M, Yettapu D, et al
    Spatial and temporal clustering of anti-SARS-CoV-2 antibodies in Illinois household cats, 2021-2023.
    PLoS One. 2024;19:e0299388.
    PubMed         Abstract available
  37. HUA MJ, Butera G, Akinyemi O, Porterfield D, et al
    Biases and limitations in observational studies of Long COVID prevalence and risk factors: A rapid systematic umbrella review.
    PLoS One. 2024;19:e0302408.
    PubMed         Abstract available
  38. CHIRAPAPAISAN N, Eiamsamarng A, Chuenkongkaew W, Rattanathamsakul N, et al
    The prone position in COVID-19 impacts the thickness of peripapillary retinal nerve fiber layers and macular ganglion cell layers.
    PLoS One. 2024;19:e0300621.
    PubMed         Abstract available
  39. YUSPAHRUDDIN A, Abbas H, Pahala I, Eliyana A, et al
    Fostering proactive work behavior: Where to start?
    PLoS One. 2024;19:e0298936.
    PubMed         Abstract available
  40. AMIO MGA, Ahmed HN, Ali SM, Ahmed S, et al
    Key determinants to supply chain resilience to face pandemic disruption: An interpretive triple helix framework.
    PLoS One. 2024;19:e0299778.
    PubMed         Abstract available
  41. YUAN JL, Jing N
    The financial risk of real estate combined factor analysis with grey prediction in Liaoning Province.
    PLoS One. 2024;19:e0301526.
    PubMed         Abstract available
  42. DEWI PEN, Sunantiwat M, Thavorncharoensap M, Youngkong S, et al
    Treatment seeking experiences of ACS patients in Yogyakarta, Indonesia during COVID-19 pandemic: A qualitative study.
    PLoS One. 2024;19:e0302320.
    PubMed         Abstract available
  43. ASUMADU ODK, Boah M, Chirawurah D, Ndago JA, et al
    Pregnancy outcomes before and during COVID-19 pandemic in Tamale Metropolis, Ghana: A retrospective cohort study.
    PLoS One. 2024;19:e0302589.
    PubMed         Abstract available
  44. ZHOU X, Huang T, Pan H, Du A, et al
    Bioinformatics and system biology approaches to determine the connection of SARS-CoV-2 infection and intrahepatic cholangiocarcinoma.
    PLoS One. 2024;19:e0300441.
    PubMed         Abstract available
  45. MARTINS P, Luzia RWS, Filho JAP, Welsh KS, et al
    Prevalence and factors associated with burnout among health professionals of a public hospital network during the COVID-19 pandemic.
    PLoS One. 2024;19:e0298187.
    PubMed         Abstract available
  46. VRABCOVA P, Scholz P, Linderova I, Kotouckova H, et al
    Eco-friendly hotels and guesthouses as a new opportunity for resilience and sustainability: Evidence from the Czech Republic.
    PLoS One. 2024;19:e0301936.
    PubMed         Abstract available
  47. HALL V, Cardona C, Mendoza K, Torchetti M, et al
    Surveillance for highly pathogenic avian influenza A (H5N1) in a raptor rehabilitation center-2022.
    PLoS One. 2024;19:e0299330.
    PubMed         Abstract available
  48. TAMARGO JA, Martin HR, Diaz-Martinez J, Delgado-Enciso I, et al
    Drug use and COVID-19 testing, vaccination, and infection among underserved, minority communities in Miami, Florida.
    PLoS One. 2024;19:e0297327.
    PubMed         Abstract available
  49. YAMAJI T, Harada T, Hashimoto Y, Nakano Y, et al
    Effects of BNT162b2 mRNA Covid-19 vaccine on vascular function.
    PLoS One. 2024;19:e0302512.
    PubMed         Abstract available
  50. HWANG LA, Vaithilingam S, Ng JWJ, Nair M, et al
    The continuance intention to vaccinate against COVID-19: An empirical study from Malaysia.
    PLoS One. 2024;19:e0301383.
    PubMed         Abstract available
  51. WEIGOLD S, Schorr SG, Faust A, Woydack L, et al
    Informed consent and trial prioritization for clinical studies during the COVID-19 pandemic. Stakeholder experiences and viewpoints.
    PLoS One. 2024;19:e0302755.
    PubMed         Abstract available
  52. JANNAT Z, Das H, Ali MW, Wahed T, et al
    Disparities in COVID-19 vaccine uptake among rural hard-to-reach population and urban high-risk groups of Bangladesh.
    PLoS One. 2024;19:e0302056.
    PubMed         Abstract available
  53. ZHANG R, Byrd T, Qiao S, Torres ME, et al
    Maternal care utilization and provision during the COVID-19 pandemic: Voices from minoritized pregnant and postpartum women and maternal care providers in Deep South.
    PLoS One. 2024;19:e0300424.
    PubMed         Abstract available
  54. DAVINA-NUNEZ C, Perez S, Cabrera-Alvargonzalez JJ, Rincon-Quintero A, et al
    Performance of amplicon and capture based next-generation sequencing approaches for the epidemiological surveillance of Omicron SARS-CoV-2 and other variants of concern.
    PLoS One. 2024;19:e0289188.
    PubMed         Abstract available
  55. ESPER TREML R, Caldonazo T, Barlem Hohmann F, Lima da Rocha D, et al
    Association of chest computed tomography severity score at ICU admission and respiratory outcomes in critically ill COVID-19 patients.
    PLoS One. 2024;19:e0299390.
    PubMed         Abstract available
  56. HU Y, Villalan AK, Fan X, Zhang S, et al
    Analysis the molecular similarity of least common amino acid sites in ACE2 receptor to predict the potential susceptible species for SARS-CoV-2.
    PLoS One. 2024;19:e0293441.
    PubMed         Abstract available
  57. ASSCHE SB, Ferraccioli F, Riccetti N, Gomez-Ramirez J, et al
    Urban-rural disparities in COVID-19 hospitalisations and mortality: A population-based study on national surveillance data from Germany and Italy.
    PLoS One. 2024;19:e0301325.
    PubMed         Abstract available
  58. ZOZMANN H, Schuler L, Fu X, Gawel E, et al
    Autonomous and policy-induced behavior change during the COVID-19 pandemic: Towards understanding and modeling the interplay of behavioral adaptation.
    PLoS One. 2024;19:e0296145.
    PubMed         Abstract available
  59. KELEYNIKOV M, Cohen N, Benatov J
    Maternal distress during the COVID-19 outbreak: A socio-ecological perspective.
    PLoS One. 2024;19:e0302266.
    PubMed         Abstract available
  60. CHUEMCHIT M, Linn N, Han CPP, Lynn Z, et al
    Discrimination and violence against women migrant workers in Thailand during the COVID-19 pandemic: A mixed-methods study.
    PLoS One. 2024;19:e0300388.
    PubMed         Abstract available
  61. ZOU Y, Pan M, Zhou T, Yan L, et al
    Critical COVID-19, Victivallaceae abundance, and celiac disease: A mediation Mendelian randomization study.
    PLoS One. 2024;19:e0301998.
    PubMed         Abstract available
  62. NEWMAN PA, Chakrapani V, Massaquoi N, Williams CC, et al
    Effectiveness of an eHealth intervention for reducing psychological distress and increasing COVID-19 knowledge and protective behaviors among racialized sexual and gender minority adults: A quasi-experimental study (#SafeHandsSafeHearts).
    PLoS One. 2024;19:e0280710.
    PubMed         Abstract available
  63. CASJENS S, Taeger D, Bruning T, Behrens T, et al
    Changes in mental distress among employees during the three years of the COVID-19 pandemic in Germany.
    PLoS One. 2024;19:e0302020.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A
  64. MAO T, Kim J, Pena-Hernandez MA, Valle G, et al
    Intranasal neomycin evokes broad-spectrum antiviral immunity in the upper respiratory tract.
    Proc Natl Acad Sci U S A. 2024;121:e2319566121.
    PubMed         Abstract available
  65. KUNG CSJ, Steptoe A
    Changes in well-being among socially isolated older people during the COVID-19 pandemic: An outcome-wide analysis.
    Proc Natl Acad Sci U S A. 2024;121:e2308697121.
    PubMed         Abstract available


    Vaccine
  66. PITTS PJ, Poland GA
    Addressing vaccine hesitancy: Learning from the successes and failures of the COVID-19 pandemic.
    Vaccine. 2024 Apr 10:S0264-410X(24)00396-7. doi: 10.1016/j.vaccine.2024.
    PubMed        
  67. BAKER J, Aliabadi N, Munjal I, Jiang Q, et al
    Equivalent immunogenicity across three RSVpreF vaccine lots in healthy adults 18-49 years of age: Results of a randomized phase 3 study.
    Vaccine. 2024 Apr 13:S0264-410X(24)00387-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  68. DEAL A, Crawshaw AF, Salloum M, Hayward SE, et al
    Understanding the views of adult migrants around catch-up vaccination for missed routine immunisations to define strategies to improve coverage: A UK in-depth interview study.
    Vaccine. 2024 Apr 16:S0264-410X(24)00406-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  69. LEE N, Hong Y, Kirkpatrick CE, Hu S, et al
    COVID-19 vaccination communication: Effects of vaccine conspiracy beliefs and message framing among black and white participants.
    Vaccine. 2024 Apr 16:S0264-410X(24)00402-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  70. PEREIRA ET, Iasulaitis S, Greco BC
    Analysis of causal relations between vaccine hesitancy for COVID-19 vaccines and ideological orientations in Brazil.
    Vaccine. 2024 Apr 16:S0264-410X(24)00436-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  71. EJNAR HANSEN M, David Pickering S
    The role of religion and COVID-19 vaccine uptake in England.
    Vaccine. 2024;42:3215-3219.
    PubMed         Abstract available
  72. FLEARY SA, Shahn Z, Teasdale CA
    Effects of parental childhood cultural health environment on children’s influenza and COVID-19 vaccination status.
    Vaccine. 2024 Apr 29:S0264-410X(24)00515-2. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


    Virology
  73. MA X, Wang Q, Xu X, Zhang W, et al
    miR-214-PTEN pathway is a potential mechanism for stress-induced immunosuppression affecting chicken immune response to avian influenza virus vaccine.
    Virology. 2024;595:110094.
    PubMed         Abstract available
  74. KIM KH, Bhatnagar N, Subbiah J, Liu R, et al
    Cross-protection against influenza viruses by chimeric M2e-H3 stalk protein or multi-subtype neuraminidase plus M2e virus-like particle vaccine in ferrets.
    Virology. 2024;595:110097.
    PubMed         Abstract available